The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike.

In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted.

In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion.

In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice.

For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead.

Snapshot of New Opportunities

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here.

Open Calls:

Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!*

Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity.

• Geographies: United States.

• Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement.

• Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000.

• Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities.

• Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026.

• Learn more and apply here.

This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution.

ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!*

AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage.

• Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye).

• Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization.

• Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS).

• Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships

• Deadline: May 5, 2026.

• Learn more and apply here.

This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains.

Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!*

Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery.

• Geographies: United Kingdom.

• Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only.

• Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands).

• Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access.

• Deadline: May 6, 2026 (11:00am).

• Learn more and apply here.

This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.

Read more

The April update for Global Health & WASH brings an unusually concentrated set of new calls that share a single underlying pressure: the distance between what we know works and who actually benefits from it. Across cancer care, nutrition, mental health, and infectious disease, funders are increasingly unwilling to pay for more efficacy evidence. They want to know how proven interventions reach more people, more consistently, at lower cost.

The most visible signal is a cluster of five simultaneous Gates Grand Challenges calls, all closing April 28, all targeting the economics of malnutrition. Two calls push for cost-disrupting breakthroughs in ready-to-use therapeutic food manufacturing. A third targets cost-disruptive diagnostics and screening tools designed for population-scale LMIC deployment. A fourth goes upstream into fetal growth restriction and placental inflammation. A fifth asks why fortified foods aren’t converting to nutritional outcomes and funds solutions to the absorption gap. Individually these are research grants. Together they read as a coordinated bet: that the barrier to ending severe acute malnutrition is no longer scientific knowledge but cost and delivery economics. That’s a meaningful shift in funder logic.

Unitaid’s cervical cancer call (~$30M) makes the same argument in a different disease area. It’s not funding more evidence on HPV screening. It’s funding market-shaping interventions that can lower prices, diversify suppliers, and embed secondary prevention into national health systems at scale. Innovate UK’s addiction healthcare contracts (GBP £20M) push near-market innovations toward TRL 6-7 in UK service settings. Wellcome’s new infectious disease clinical trial call funds optimization trials, dosing, targeting, pragmatic effectiveness in routine contexts, not new efficacy studies. The pattern is consistent: the science has done its job, now fund the adoption.

Two new calls stand out as outliers worth watching. RWJF’s health knowledge systems call is unusual, it’s funding projects that expand what “counts” as health knowledge and protect community and Indigenous knowledge from erosion in an environment of public misinformation and institutional pressure. That’s a systems-level equity intervention dressed as a research call. Rare Impact Fund’s nonclinical mental health workforce call is similarly structural: it’s funding the pipeline of peer support specialists, community health workers, and care navigators that extend clinical reach, treating workforce architecture as a health system intervention in its own right. And the two new WRF calls signal something quieter but worth noting — water utilities are being asked to reckon with AI adoption and affordability equity simultaneously, with evidence standards applied to both.

For researchers and implementers, the Gates cluster rewards teams that combine scientific rigor with manufacturing or delivery economics — proposals that treat cost reduction as a primary design constraint, not an afterthought. For global health organizations working in cancer or infectious disease, Unitaid and Wellcome both signal the same competitive posture: show how your intervention changes system behavior at scale, not just outcomes in a controlled trial. For practitioners in mental health and community health workforce development, the Rare Impact Fund call is rare in its specificity — it wants pipeline connectivity from recruitment through retention, and it wants shareable evidence that elevates the legitimacy of nonclinical roles across the field. The Pfizer cluster this month — spanning prostate cancer, migraine, rheumatology, breast cancer, adult vaccination, and mold infections across multiple geographies — is collectively the largest independent medical education portfolio in this edition, and organizations with HCP education infrastructure should read it as a full portfolio opportunity, not separate calls.

Snapshot of New Opportunities

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 42 open opportunities- 34 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here.

Open Calls:

Open Call for Expression of Interest for the Health and HIV of the 2026-2030 Uganda Country Programme, UNICEF. *New!*

UNICEF is selecting partners to address persistent preventable mortality and stalled gains in Uganda by reinforcing the foundations of primary health care and community health systems while targeting high-burden gaps in maternal and newborn health, adolescent health and HIV, and immunization. The call’s logic emphasizes resilient service delivery: stronger community platforms, improved referral and data use, better continuity of care, and preparedness for recurrent outbreaks and climate-linked health emergencies. UNICEF also signals a digital-health orientation, explicitly calling for tools such as GIS, data visualization, and data platforms to strengthen planning, early detection, and response. The intended results are framed as government and partner capacity gains at national and sub-national levels, with annual workplans designed to align actors and reduce duplication across the health ecosystem.

• Geographies: Uganda.

• Who can apply: Non-profits.

• Funding amount: Funding amount not found.

• Targeted Sectors / SDGs: Health; Focus areas: maternal and newborn health, immunization, primary health care, community health, adolescent health and HIV, public health emergencies, digital health interventions

• Deadline: April 6, 2026.

• Learn more and apply here.

UNICEF is prioritizing durable PHC capacity and outbreak-ready systems, so partners that can link frontline delivery with governance, data, and resilience will align best.

Open Call for Expression of Interest: GoU-UNICEF Nutrition Programme 2026 - 2030, UNICEF. *New!*

UNICEF is selecting implementing partners to accelerate Uganda’s nutrition outcomes by tackling two linked bottlenecks: persistently poor diets and practices across the life course, and low coverage and quality of wasting detection and treatment in both development and emergency contexts. The call is framed around systems change rather than isolated service delivery, emphasizing strengthened national and sub-national capacity to shape food systems with a child lens, improve affordability and equity of diets and services, and increase timely identification, referral, and treatment of child wasting. UNICEF’s results framing also signals a focus on vulnerable geographies and populations, including those affected by climate shocks and displacement, with attention to disability inclusion. Partners are expected to contribute to measurable progress on dietary diversity and reductions in wasting and stunting through coordinated annual workplans aligned to government leadership and multi-partner delivery.

• Geographies: Uganda.

• Who can apply: Non-profits.

• Funding amount: Funding amount not found.

• Targeted Sectors / SDGs: Health; Focus areas: infant and young child feeding, wasting prevention and treatment, micronutrients, nutrition systems and policy, nutrition in emergencies

• Deadline: April 8, 2026.

• Learn more and apply here.

This is a systems-first nutrition call, so UNICEF is effectively selecting for partners who can connect diet improvement and wasting treatment pathways to measurable population-level outcomes.

MedTech Impact Call 2026, IHFC (Technology Innovation Hub of IIT Delhi). *New!*

IHFC, in collaboration with India Accelerator, seeks to surface and accelerate high-potential MedTech and HealthTech startups that can materially strengthen healthcare delivery, prevention, and system performance in India. The call is framed around a broad pipeline of solution areas, spanning digital care models, AI-enabled health decisioning, advanced devices, biotech innovation, health infrastructure, and preventive and public health technologies. Beyond visibility, the program’s structure signals a practical scale-readiness lens: selected teams are positioned to benefit from targeted mentorship, academic support, and industry connections intended to de-risk execution and shorten pathways to adoption. Funding is presented as a key lever to help startups translate validated prototypes into deployable products and partnerships, with an emphasis on teams that can demonstrate both technical maturity and a credible business plan.

• Geographies: India.

• Who can apply: India-registered early or growth-stage startups with prototype, MVP, or validation (TRL 4 or higher) and at least 2 full-time founders.

• Funding amount: Funding up to INR 5 Cr.

• Targeted Sectors / SDGs: Health; Focus areas: digital health and telemedicine, AI and data-driven health, medical devices, biotech, health infrastructure and systems, preventive and public health technology, robotics in healthcare.

• Deadline: April 8, 2026.

• Learn more and apply here.

This is a capital-plus-support pathway designed to move mature, India-ready health innovations toward real-world uptake through ecosystem linkages.

Optimizing HRRm Testing and Workflow Integration in mCSPC, Pfizer.

Pfizer’s Research and Quality Improvement competitive grant program seeks to strengthen how homologous recombination repair mutation (HRRm) testing is implemented and integrated into care pathways for metastatic castration-sensitive prostate cancer (mCSPC) in Canada. The call prioritizes projects that move beyond technical validation to address real-world system challenges—such as fragmented workflows, delayed testing, and inequitable access—through implementation science or applied research. Funded initiatives are expected to demonstrate sustainability beyond the grant period, with particular emphasis on standardized testing pathways, multidisciplinary coordination, and measurable improvements in turnaround times, referral processes, and patient access. Pfizer’s investment logic favors proposals that align with established clinical guidelines, leverage cross-institutional collaboration, and generate actionable evidence that can inform broader adoption across Canadian healthcare settings. By supporting quality improvement and system-level research rather than clinical efficacy studies, the program aims to accelerate practical improvements that translate existing knowledge into more consistent, equitable oncology care.

• Geographies: Canada.

• Who can apply: Healthcare institutions, academic or professional schools, professional organizations, government agencies, and other organizations focused on healthcare improvement.

• Funding amount: CAD $20,000–100,000 per project.

• Targeted Sectors / SDGs: Health; Focus areas: precision oncology, diagnostic workflows, implementation science.

• Deadline: April 8, 2026.

• Learn more and apply here.

This call rewards proposals that treat testing not as a lab issue but as a system challenge—where workflow design, team integration, and sustainability determine real-world impact.

Programma per la prevenzione e cura dei tumori in Bosnia ed Erzegovina (AID 013078/01/0), Agenzia Italiana per la Cooperazione allo Sviluppo (AICS).

AICS is funding a large-scale, systems-oriented initiative to consolidate and expand breast cancer prevention and treatment services across Bosnia and Herzegovina, building on a successful pilot that established the country’s first organized mammography screening program in the Zenica-Doboj Canton. The call seeks an experienced civil society implementer capable of strengthening decentralized health systems by scaling screening coverage, standardizing clinical and administrative protocols, and upgrading service infrastructure across multiple cantons and the Republika Srpska. A core priority is workforce development: healthcare professionals previously trained under the pilot phase are expected to act as knowledge multipliers, transferring expertise to new regions and fostering a cross-entity professional network. The initiative is framed around Result-Based Management, positioning the project as a replicable national model for women’s oncological care.

• Geographies: Bosnia and Herzegovina (Una-Sana, Bosnia-Podrinje, Tuzla, Zenica-Doboj, Republika Srpska).

• Who can apply: Italian-registered CSOs and eligible non-profits listed under Art. 26(3) Law 125/2014; ATS allowed.

• Funding amount: Total allocation EUR €2,000,000.00.

• Targeted Sectors / SDGs: Health; Focus areas: breast cancer screening, mammography services, provider capacity building, health systems strengthening.

• Deadline: April 8, 2026 (15:00 CET).

• Learn more and apply here.

This call reflects AICS’s strategy of scaling proven pilot models into system-wide reforms within decentralized health systems.

Accelerating Cervical Cancer Elimination through Secondary Prevention in Low- and Middle-Income Countries, Unitaid.

Unitaid is calling for large-scale, catalytic proposals to accelerate global cervical cancer elimination by transforming access to secondary prevention in low- and middle-income countries. The initiative targets persistent gaps in screening, triage, and treatment of pre-cancerous lesions, with a clear emphasis on overcoming market and delivery barriers that limit uptake at scale. Rather than funding stand-alone pilots, Unitaid seeks interventions capable of reshaping markets — lowering prices, diversifying suppliers, and integrating innovations into national health systems in line with WHO elimination targets. Successful proposals are expected to combine technical innovation with health system integration and sustainable access strategies, delivering population-level impact for women and girls who remain underserved.

• Geographies: Low- and middle-income countries across Africa, Asia, and Latin America.

• Who can apply: Consortia of organizations with implementation, technical, and market-shaping expertise.

• Funding amount: Approximately USD $30 million total across all selected projects.

• Targeted Sectors / SDGs: Health; Focus areas: cervical cancer secondary prevention, HPV screening, access to diagnostics.

• Deadline: April 9, 2026.

• Learn more and apply here.

This call exemplifies Unitaid’s model of using market-shaping investment to convert proven health tools into equitable, large-scale access for women in LMICs.

Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patients (Spain) – Pfizer QI Competitive Grant Program, Pfizer.

Pfizer is seeking pragmatic quality improvement initiatives in Spain that close routine-care gaps in the non-pharmacological management of adverse events associated with ALK tyrosine kinase inhibitors for metastatic ALK-positive NSCLC. The funder’s framing prioritizes interventions that standardize and embed evidence-based supportive care practices so that toxicity management is more consistent across sites and sustained over time, protecting adherence and patient quality of life as treatment duration increases. Rather than funding novel clinical research, the program is designed to translate what is already known into implementable care processes, including education and engagement tools for patients and care teams, structured symptom monitoring (including patient-reported outcomes), and better care coordination across multidisciplinary services. Proposals with a patient-centered, real-world workflow orientation and measurable outcomes are positioned as the strongest fit.

• Geographies: Spain.

• Who can apply: Eligible organizations (for example professional schools, healthcare institutions, professional organizations, government agencies); individuals are not eligible.

• Funding amount: Up to EUR €40,000 per project; total pool EUR €140,000.

• Targeted Sectors / SDGs: Health; Focus areas: ALK-positive lung cancer, adverse event management, supportive care pathways, symptom monitoring, patient-reported outcomes

• Deadline: April 9, 2026 (23:59 Eastern Standard Time).

• Learn more and apply here.

This is a “standardization and uptake” call, so the most competitive proposals will specify the care process changes, the metrics that prove reduced variation, and how the model will be sustained after the grant period.

Read more

The March funding cycle for global health is moving decisively away from the lab and toward the “last mile” of care. We are seeing a massive cluster of new opportunties, including over 18 brand-new open calls, that prioritize implementation science and workflow optimization over pure drug discovery. Large-scale envelopes from Unitaid ($55M total across two calls) and Pfizer are no longer just buying products; they are resourcing the supply chain “plumbing” and care pathways needed to ensure that medical innovation actually reaches the community level. This shift suggests that for practitioners, the winning strategy for 2026 is proving you can fix a system bottleneck—like referral clarity or diagnostic turnaround times—rather than just delivering another pilot project.

We are also observing a powerful new mandate for “Decision-Grade Evidence”. New infrastructure plays, like Wellcome’s $9M+ Evidence Synthesis Hubs, are funding the AI-enabled capability to turn fragmented data into policy action in real-time. This is being paired with high-stakes research pipelines for Brain Health in Denmark and RNA therapeutics in Canada, where the goal is to build durable national backbones for high-tech health delivery. With an actionable pool of over $250 Million USD in this sector alone, the March landscape is rewarding “Systemic Readiness”—the ability to integrate bold science into the messy, practical reality of national health grids.

Snapshot of New Opportunities

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 49 open opportunities- 18 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 13 rolling opportunities!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to pay what you can rates. You can find more details here.

Open Calls:

Roux Prize – 2026 Call for Nominations, Institute for Health Metrics and Evaluation (IHME). *Closing soon!*

The Roux Prize is an annual international award that celebrates individuals or groups who have used health evidence in bold, innovative ways to improve population health. Administered by the Institute for Health Metrics and Evaluation, the prize emphasizes real‑world impact from evidence such as global disease burden data, rewarding not just research but application that drives health improvements for communities or populations.Rather than financing project proposals, the prize recognizes impactful translation and application of data- from burden of disease metrics to policy, practice, or implementation at scale. Nominations are peer‑sourced and evaluated by an expert committee, with the award spotlighting ingenuity in evidence use and the power of data to drive lasting health gains.

• Geographies: Global, individuals and groups from any country may be nominated.

• Who can apply: Individuals or groups nominated by others (not self‑nominated) whose work demonstrates impactful use of health evidence.

• Funding amount: USD $100,000 (prize).

• Targeted Sectors / SDGs: Public Health; Focus areas: evidence‑to‑impact, population health improvement.

• Deadline: March 3, 2026.

• Learn more and nominate here.

IHME values innovation in evidence application - nominations should clearly articulate how evidence changed health outcomes or policy decisions.

2025 R2a Project Grant, Auckland Medical Research Foundation. *Closing soon!*

The Auckland Medical Research Foundation’s R2a Project Grant supports high-quality, investigator-led research designed to improve the health and quality of life of New Zealanders. The Foundation seeks biomedical, bioengineering, clinical, and population or public health projects that demonstrate strong scientific merit, clear relevance to New Zealand health priorities, and a credible pathway to clinical, system, or population-level impact. Priority is placed on projects led from recognized institutions in the greater Auckland and Northland region, with the expectation that the majority of work is undertaken locally while allowing national or international collaboration where it strengthens the science. AMRF’s funding logic favors standalone, clearly defined research programs rather than top-up funding for large external grants, and places strong emphasis on feasibility, ethical compliance, and appropriate budgeting. By capping funding at NZD $200,000 over two years and excluding overheads, the program is designed to catalyze focused, high-impact research grounded in local leadership and accountability.

• Geographies: Greater Auckland and Northland region, New Zealand.

• Who can apply: Principal investigators affiliated with recognized tertiary institutions, DHBs, or CRIs in Auckland/Northland; national and international co-applicants permitted.

• Funding amount: Up to NZD $200,000 total over a maximum of 2 years.

• Targeted Sectors / SDGs: Health; Focus areas: biomedical research, clinical impact, public health research.

• Deadline: March 4, 2026 (5:00 pm NZT).

• Learn more and apply here.

This grant reflects AMRF’s strategy of backing locally led, rigorously designed research that can translate into tangible health gains for New Zealand communities.

Oxford-Harrington Rare Disease Scholar Award (2026), Oxford-Harrington Rare Disease Centre. *Closing soon!*

The Oxford-Harrington Rare Disease Scholar Award seeks to de-risk and accelerate rare disease therapeutic programs by pairing non-dilutive grant funding with hands-on drug development support and access to specialized platforms. The funder’s logic is explicitly translational: it prioritizes novel, validated targets and any therapeutic modality, with emphasis on neurological disorders, developmental and metabolic disorders, and rare cancers, while remaining open to other high–unmet-need rare genetic indications. What’s distinctive is the structure beyond the check, each Scholar is surrounded by a therapeutics development team (including industry-experienced leaders) and dedicated project management, with milestone-based potential renewal and follow-on acceleration and investment pathways. The program is designed to move academic discoveries toward clinic-ready packages while allowing awardees or their institutions to retain IP, signaling an intent to catalyze downstream translation rather than capture ownership.

• Geographies: United Kingdom; United States; Canada.

• Who can apply: MD or PhD (or equivalent) researchers in the UK, US, and Canada operating their own independent lab.

• Funding amount: Guaranteed: USD $100,000 (US/Canada) or £100,000 (UK); additional acceleration funds up to USD $300,000/£250,000; potential investment up to USD $1,000,000.

• Targeted Sectors / SDGs: Health; Focus areas: rare disease therapeutics, neurology, developmental and metabolic disorders, rare cancers, target validation.

• Deadline: March 9, 2026.

• Learn more and apply here.

This is an “execution-capital” award: Oxford-Harrington is underwriting the capabilities and development discipline that most academic rare-disease programs lack at the point of translational inflection.

Youth Mental Health Grant 2026, Kindred Foundation. *Closing soon!*

Kindred Foundation seeks to strengthen direct, community-rooted mental health support for youth in Canada by funding initiatives designed specifically for Black youth, 2SLGBTQ+ youth, and youth living with a physical disability. The grant’s strategy concentrates resources on smaller organizations delivering accessible, culturally responsive supports through arts-based and physical activity-based models, reflecting a preference for approaches that combine belonging, participation, and wellbeing outcomes. Two dedicated funding streams are designed to ensure review and decision-making are guided by lived experience and community expertise, while eligibility rules emphasize leadership and partnership with the communities served. The structure signals an implementation focus, prioritizing tangible participant engagement and clear mental health outcomes over general awareness, research, or event-based programming. This is a targeted effort to shift mental health resourcing toward community-led models where trust, access, and fit determine real uptake.

• Geographies: Canada (North America).

• Who can apply: Canadian organizations providing direct support through arts-based or physical activity-based initiatives that promote mental health for eligible youth communities; must be a registered Canadian charity or affiliated with a qualified donee.

• Funding amount: Total pool: CAD $255,000; Focused stream funding includes CAD $60,000 (1 grant), up to CAD $30,000 (approximately 3 grants), and up to CAD $35,000 (approximately 3 grants).

• Targeted Sectors / SDGs: Health; Focus areas: youth mental health, arts-based initiatives, physical activity-based initiatives, disability inclusion, LGBTQ+ inclusion

• Deadline: March 9, 2026.

• Learn more and apply here.

Kindred is signaling that the strongest proposals will demonstrate direct youth engagement, clear mental health outcomes, and credible community leadership or partnership.

2026 LCRF Prevention and Early Detection Research Grant Program, Lung Cancer Research Foundation. *Closing soon!*

LCRF’s Prevention and Early Detection track backs research that can shift lung cancer outcomes upstream—reducing incidence where possible and detecting disease earlier when survival prospects are strongest. The funder prioritizes projects that improve risk stratification and screening uptake, develop or validate biomarker-driven approaches (including liquid biopsy and molecular techniques), and advance imaging or computational modalities that can identify pre-neoplastic processes and early-stage disease. A distinctive feature of this mechanism is its openness to implementation-oriented research that accelerates systematic uptake of evidence into routine practice—reflecting LCRF’s interest in solutions that move beyond discovery to operational impact in real care settings. Review criteria emphasize feasibility and potential field influence, rewarding proposals with clear logic from method to measurable outcomes and a plausible path to broader adoption. The aim is to produce actionable evidence that can expand who benefits from early detection and prevention advances.

• Geographies: Global.

• Who can apply: Post-docs, clinical fellows, and early-/mid-career investigators (<7 years since initial faculty appointment) at non-profit academic/research institutions (U.S. and international eligible).

• Funding amount: USD $150,000 over 2 years (USD $75,000 per year).

• Targeted Sectors / SDGs: Health; Focus areas: early detection, screening, liquid biopsy

• Deadline: March 10, 2026.

• Learn more and apply here.

By funding both discovery and implementation pathways, this call is designed to convert early-detection innovation into population-level survival gains.

Read more

The February 2026 Global Health and WASH cycle is characterized by a high volume of opportunities focusing on service integration and diagnostic precision. We are observing a significant cluster of funding dedicated to nursing-led care models and oncology workflow optimization, suggesting that the current emphasis has shifted from broad clinical trials toward the practical “how-to” of delivering care in community settings.

This month, the data highlights a clear interest in localization and institutional resilience. Through large-scale calls from Unitaid and ViiV Healthcare, we see a focus on transition strategies, specifically how community-led interventions can eventually become part of durable, government-owned systems.

This month’s landscape reflects a sector that is increasingly looking for “implementation-ready” partners who can bridge the gap between medical evidence and daily clinical practice.

Snapshot of New Opportunities

This month features a heavy concentration of funding in translational medicine and community-led equity models.

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 40 open opportunities- 21 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 13 rolling opportunities- 1 new!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

New Investigator Research Grant Program 2026, Leukemia Research Foundation. *Closing soon!*

This annual research funding opportunity empowers early‑career investigators to pursue highly innovative leukemia and myelodysplastic syndromes (MDS) research with strong potential for scientific breakthroughs. The program seeks proposals that demonstrate originality, methodological rigor, and relevance to advancing understanding or treatment of leukemia and related blood cancers. With a clearly competitive two‑stage process (letter of intent followed by invitation‑only full proposal), the Foundation emphasizes feasibility, impact, and research independence. Applicants are encouraged to highlight novel approaches and preliminary data that position their work to fill critical gaps in leukemia science.

• Geographies: Global.

• Who can apply: Independent investigators at non‑profit academic institutions within 7 years of their first independent faculty appointment.

• Funding amount: Up to US $150,000 over 2 years.

• Targeted Sectors / SDGs: Health; Focus areas: leukemia research, myelodysplastic syndromes, translational and innovative projects.

• Deadline: February 6, 2026 (12 pm CT) for LOI.

• Learn more and apply here.

The Foundation prioritizes early‑career scientists whose innovative research could catalyze new insights and treatments in leukemia, with a rigorous review by expert advisors and clear guidelines on resource use and research independence.

Epidemiology and Surveillance of Gram-negative Infections Caused by CPOs (UK), Pfizer. *Closing soon!*

Pfizer invites research institutions and eligible UK-based organizations to apply for competitive grants supporting epidemiological surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs). These infections are a growing public health concern with limited therapeutic options. This opportunity prioritizes projects that examine resistance mechanisms, explore links between colonisation and infection, and assess healthcare system impact across the UK’s four nations. The initiative aims to generate data that improve patient outcomes, treatment protocols, and policy design around antimicrobial resistance. Research must focus on clinical implications, antimicrobial susceptibility, and cross-regional trends, with strong emphasis on data-sharing and translational relevance.

• Geographies: United Kingdom (England, Scotland, Wales, Northern Ireland).

• Who can apply: UK-based academic or research institutions, healthcare facilities, and nonprofit entities with qualified investigators.

• Funding amount: GBP £50,000 per project; total pool: GBP £100,000.

• Targeted Sectors / SDGs: Scientific Research; Focus areas: CPO surveillance, antibiotic resistance, Gram-negative pathogens.

• Deadline: February 6, 2026.

• Learn more and apply here.

Pfizer prioritizes evidence-backed solutions. Proposals should clearly demonstrate how findings will guide antimicrobial stewardship and inform national surveillance frameworks.

Joint Transnational Call 2026 (JTC2026), ERDERA – European Rare Diseases Research Alliance. *Closing soon!*

This 2026 call supports multinational, interdisciplinary consortia advancing diagnostic research for rare diseases with a focus on solving undiagnosed genetic cases and tackling underexplored non-genetic conditions. ERDERA seeks projects that apply multi-omics, functional validation, advanced biostatistics, AI models, and systems biology to clarify complex disease mechanisms. Strong emphasis is placed on FAIR data, integration of clinical and real-world evidence, and development of tools to enhance diagnostic precision and accessibility. Proposals must center patients as partners across the full research lifecycle.

• Geographies: Austria, Belgium, Canada, Czech Republic, Estonia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, Switzerland, Türkiye.

• Who can apply: Multinational consortia of 3–6 partners including academia, clinical/public health bodies, SMEs, and patient groups.

• Funding amount: Up to EUR €300,000 per partner; max project duration 3 years.

• Targeted Sectors / SDGs: Health; Focus areas: undiagnosed rare diseases, functional genomics, AI tools, diagnostic platforms, FAIR data.

• Deadline: February 12, 2026 (14:00 CET).

• Learn more and apply here.

The call rewards diagnostic innovation rooted in patient experience, data stewardship, and cross-sector collaboration — explicitly excluding therapy development or clinical trials.

Positive Action Momentum Paediatrics 2026 – Scaling Evidence-Based Community Responses to Paediatric HIV, ViiV Healthcare Positive Action. *New!* *Closing soon!*

The Positive Action Momentum Pediatrics 2026 funding round seeks to reverse stalled progress on pediatric HIV by scaling community-led interventions that have already demonstrated effectiveness. Rather than funding pilots, this call is explicitly designed to expand and replicate proven approaches that increase early infant diagnosis, improve pediatric and adolescent testing coverage, strengthen linkage to care, and achieve sustained viral suppression. The program prioritizes children, adolescents, pregnant and breastfeeding women, and caregivers, with mandatory alignment to national HIV strategies and close collaboration with health facilities. A defining feature of the call is its emphasis on sustainability and health system integration — applicants must demonstrate how community-delivered services will transition into durable, government-owned systems. Grounded in localization and decolonization principles, Positive Action prioritizes locally led organizations embedded in affected communities, positioning community leadership as essential infrastructure for long-term HIV impact.

• Geographies: Angola, Cameroon, Democratic Republic of Congo, Mozambique, Tanzania.

• Who can apply: Community-based and non-governmental organizations, with priority to locally led entities.

• Funding amount: Up to GBP £300,000 over three years (up to £100,000 per year).

• Targeted Sectors / SDGs: Health; Focus areas: pediatric HIV prevention and treatment, PMTCT, early infant diagnosis, adolescent retention in care.

• Deadline: February 17, 2026 (23:59 GMT).

• Learn more and apply here.

Positive Action prioritizes localization in practice, not rhetoric - community governance, leadership, and remuneration should be visible throughout the proposal.

CaixaImpulse Health Innovation Call 2026, ”la Caixa” Foundation — CaixaResearch. *Closing soon!*

The CaixaImpulse Health Innovation Call 2026 supports the translation of biomedical research into validated, market‑ready solutions across life sciences and human health. This multi‑stage program offers tailored support for projects at different maturity levels: Stage 1 for proof‑of‑concept testing, Stage 2 for validation and prototype refinement, and Stage 3 for advanced characterization and exploitation strategy development. In addition to financial backing, the program provides mentoring, expert guidance, and specialized training to accelerate valorization and commercialization.

• Geographies: Spain; Portugal.

• Who can apply: Public‑sector or non‑profit R&D institutions (universities, research centers, hospitals, technology centers) that own or co‑own the biomedical asset(s).

• Funding amount: Up to €700,000 total (Stage 1: €50K; Stage 2: €150K; Stage 3: €500K).

• Targeted Sectors / SDGs: Life Sciences & Health; Focus areas: therapeutics, medical devices, diagnostics, digital health innovation.

• Deadline: February 19, 2026 (14:00 CET).

• Learn more and apply here.

This call is designed to bridge the gap between biomedical discovery and real‑world health innovations, enabling research teams to refine and validate assets with clear paths to market adoption.

Read more

Global health in early 2026 is navigating a fascinating "double-helix" of priorities: one strand focused on hyper-local equity and the other on high-stakes pandemic preparedness. This month, we’re seeing a significant push for anti-racist maternal health initiatives in the UK and LGBTQ+ healthcare in Malaysia, running parallel to massive investments from ARIA and CEPI into "Disease X" and innate immunity. There is also a distinct trend toward climate-resilient health products—recognizing that medicines and diagnostics are useless if they can't survive the rising heat in the Global South. Whether you are a grassroots collective in the Caribbean or a biotech consortium in Helsinki, the 2026 mandate is clear: health systems must be as inclusive as they are technologically advanced.

Snapshot of New Opportunities

This month features a heavy concentration of funding in translational medicine and community-led equity models.

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 27 open opportunities- 16 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 11 rolling opportunities- 1 new!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Reducing Inequalities in Black Maternal Health Grants, JRNY Consulting (on behalf of Impact on Urban Health & NHS South East London). *New!* *Closing soon!*

Inviting applications from community‑led initiatives that improve maternal and neonatal health outcomes for Black mothers, birthing people, and their families across South East London. This call emphasizes anti‑racist, trauma‑informed approaches and community co‑design rooted in lived experiences. Applicants are invited to respond to co‑developed solution areas that emerged from participatory workshops and expert guidance. Grants may support multi‑year work (up to three years) focusing on service innovation, community outreach, workforce development, and systemic change within local maternity and neonatal care ecosystems.

• Geographies: South East London, United Kingdom.

• Who can apply: Voluntary, community and social enterprise (VCSE) organizations or community interest companies (CICs) based in or serving South East London; partnerships or consortia are eligible if led by a community organization.

• Funding amount: £1.5 million total; individual awards may vary (indicative max ~£400k for single org, ~£600k for consortia).

• Targeted Sectors / SDGs: Public Health; Focus areas: Black maternal health, anti‑racism, trauma‑informed care, service innovation.

• Deadline: January 10, 2026 (10:00 AM).

• Learn more and apply here.

This initiative aims to disrupt health inequities by empowering community‑rooted actors to lead solutions that center Black voices and strengthen care systems in South East London.

RITC2026 – Responsible Implementation of Individualized Cancer Management Using Multi-Modal Data, ERA PerMed (EP PerMed). *Closing soon!*

EP PerMed’s 2026 call invites transnational research proposals that apply personalized medicine approaches to oncology using integrated, multi-modal data: from genomics to digital biomarkers. Projects must be implementation-focused and demonstrate both interdisciplinary collaboration and potential clinical impact. This is a two-stage process open to consortia spanning at least three of the 25 participating countries or regions.

• Geographies: Austria, Belgium (Flanders & Wallonia), Czech Republic, Estonia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal (Centro), Romania, Slovak Republic, South Africa, Spain (Andalusia & Navarre), Sweden, Türkiye.

• Who can apply: Consortia of 3–6 partners from at least 3 eligible countries; eligibility governed by national funders.

• Funding amount: Typically €300,000–€1.5M per project (exact amount depends on funder).

• Targeted Sectors / SDGs: Primary Sector: Scientific Research; Focus areas: personalized medicine, multimodal oncology data, translational implementation.

• Deadline: Pre-proposals: January 12, 2026; Full proposals: April 27, 2026.

• Learn more and apply here.

This call pushes the frontier of data-integrated, patient-specific oncology care from theory into practice.

Senior Program Coordinator – Maternal and Newborn Health Program (Malawi), CDC Foundation. *Closing soon!*

The CDC Foundation is hiring a Malawi-based Senior Program Coordinator to lead implementation and coordination for a new maternal and newborn health initiative. The role will support government partners and local implementers across targeted districts, focusing on improving access to quality childbirth services and emergency obstetric and newborn care. Responsibilities include strategy coordination, oversight of implementing partners, and data-driven program improvement. The position is funded through a private philanthropic grant and involves full-time engagement for 12 months, with potential renewal.

• Geographies: Malawi.

• Who can apply: Individual consultants with public health expertise, residency in Malawi, and relevant senior-level experience.

• Funding amount: USD $73,000–98,000 (12-month contract).

• Targeted Sectors / SDGs: Health; Focus areas: maternal health, neonatal health, systems strengthening.

• Deadline: January 15, 2026 (17:00 Central Africa Time).

• Learn more and apply here.

With deep links to Malawi’s Ministry of Health, this role offers a rare opportunity to drive high-impact public health work from within the system.

Healthy Cities with Pride — Small Grants Program (Malaysia), Jejaka. *New!* *Closing soon!*

Jejaka is launching the “Healthy Cities with Pride” initiative, offering small grants to support LGBTQ+ and HIV‑focused community work across select Malaysian cities. This program offers six months of funding (with potential extensions) to empower community‑led efforts that advance inclusive health and rights‑based services. With an emphasis on accessibility and flexibility, this fund is open to both formal and informal actors — including registered organizations, grassroots collectives, and individual community leaders. Activities may range from peer‑led health education and safe space creation to community outreach and organizational development.

• Geographies: Penang, Kuching (Sarawak), Kota Kinabalu (Sabah), Pahang, Terengganu & Kelantan.

• Who can apply: Registered organizations, informal groups/collectives, and individual community leaders (registration not required).

• Funding amount: RM10,000–RM60,000 (~USD $2,100–12,700).

• Targeted Sectors / SDGs: Public Health; Focus areas: LGBTQ+ inclusion, HIV response, grassroots engagement.

• Deadline: January 16, 2026.

• Learn more and apply here.

This program centers the lived realities of marginalized communities — pairing grassroots leadership with practical, localized resources to advance health and dignity.

Mental Health Scale-Up Fund, Community Foundation for Surrey (CFSurrey). *Closing soon!*

This fund provides multi‑year grants to expand community-based mental health and wellbeing services across Surrey, UK. It seeks to scale up interventions that have already shown positive impact, aiming to reach underserved populations including children, youth, families, and marginalized groups, and to extend services geographically or adapt them for new cohorts. The fund supports a wide range of preventive and supportive mental health approaches- from counselling and peer support to nature-based therapy, community outreach, and suicide-prevention programs.

• Geographies: Surrey, United Kingdom.

• Who can apply: Registered non-profit/VCSE organizations, community groups, charities or community interest companies with social purpose (statutory bodies and for‑profits are not eligible).

• Funding amount: Up to £75,000 per year for up to 5 years.

• Targeted Sectors: Health / Wellbeing; Focus areas: youth mental health, community mental health services, preventive support, scale-up of proven interventions.

• Deadline: January 19, 2026 (EOI).

• Learn more and apply here.

Projects that combine proven impact, clear scalability plans and strong community outreach, especially reaching excluded or high-need groups, will be most competitive under this fund.

Improving access to diagnostics through the adoption of tools and approaches that drive integration, Unitaid. *Closing soon!*

Seeks to transform diagnostic access by enabling countries to design and deploy integrated diagnostic strategies that cut across diseases, levels of care and service delivery models. The call supports proposals that bolster demand and adoption of techniques such as multi‑disease, multi‑modal tests, strengthen market entry/commercialization pathways, and build sustainable financing and supply chain ecosystems in low‑ and middle‑income countries. It emphasizes people‑centered, equitable deployment at decentralized levels, strong linkages to care, and alignment with national diagnostic systems.

• Geographies: Global, focused on low‑ and middle‑income countries (LMICs) in multi‑country (4‑5 country) projects.

• Who can apply: Organizational applicants (consortia or leads) working in LMICs with country‑level partnerships; South‑based implementers encouraged.

• Funding amount: Approximate total pool USD $25 million. Funding will be allocated based on the select project needs.

• Targeted Sectors / SDGs: Primary Sector: Diagnostics & testing tools; Focus areas: integrated diagnostics, multi‑disease platforms, decentralized testing, linking diagnostics to care pathways.

• Deadline: January  19,  2026 (12:00 noon CET)

• Learn more and apply here.

This call spotlights diagnostics as a foundational lever: by investing in integrated, ecosystem‑aware diagnostic solutions, Unitaid aims to enable earlier detection, improved linkage to care, and more resilient health systems across multiple diseases in underserved settings.

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 27 open opportunities- 12 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 7 rolling opportunities!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 7 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Small Grants for Community WASH Projects in Asia & Oceania, Luena Foundation. *Closing soon!*

Luena Foundation is offering microgrants to support locally led, community-based initiatives that enhance access to safe water, sanitation, and hygiene in Asia and Oceania. This call targets small-scale, high-impact projects serving vulnerable children and families—especially in rural and under-resourced settings. Projects might include borehole repair, latrine construction, school hygiene programs, or innovative purification solutions. Applicants must be local nonprofits with boards and staff from the communities they serve and must contribute 25% of project costs via cash, labor, or materials.

• Geographies: Cambodia, Laos, Vietnam, Myanmar, Thailand, Malaysia, Bhutan, Indonesia, Philippines, Timor-Leste, Nepal, Bangladesh, India, Sri Lanka, Pakistan, Kyrgyzstan, Tajikistan, Mongolia, Papua New Guinea, Fiji, Solomon Islands, Vanuatu, Samoa, Tonga, Kiribati, Tuvalu, Micronesia (FSM, Palau, Marshall Islands, Nauru).

• Who can apply: Locally led, registered nonprofit or community-based organizations.

• Funding amount: Grants range USD $1,000 - $1,500.

• Targeted Sectors / SDGs: Water & Sanitation; Focus areas: safe water access, hygiene, child health.

• Deadline: December 1, 2025 (Local Time).

• Learn more and apply here.

These small but catalytic grants aim to enable community-driven solutions in settings where WASH gaps are greatest.

Gavi CSO Funding – Nigeria Call for Proposals, Gavi, the Vaccine Alliance. *Closing soon!*

Inviting Nigerian CSOs to apply for catalytic grants under its CSO Funding Mechanism, targeting ten priority states and the FCT. This call prioritizes locally led partnerships that can drive equitable immunization outcomes through results-based, verifiable impact. Three focus areas define this round: increasing routine immunization coverage and reducing zero-dose children; rolling out HPV vaccines with improved uptake among eligible girls; and integrating COVID-19 vaccines into standard immunization systems.

• Geographies: Nigeria.

• Who can apply: Nigerian-registered CSOs with demonstrated health sector experience; CBO partnerships required.

• Funding amount: USD $400,000–$1M per grant; total pool of USD $6.5M.

• Targeted Sectors / SDGs: Health; Focus areas: zero-dose children, HPV roll-out, routine COVID-19 integration.

• Deadline: December 2, 2025, 16:00 WAT.

• Learn more and apply here.

Gavi seeks verifiable impact through locally rooted CSO partnerships that advance immunization equity and integration in Nigeria’s most underserved communities.

Development of Continuous C-Peptide Monitoring Technologies, Breakthrough T1D. *New!* *Closing soon!*

Breakthrough T1D is seeking proposals to develop real-time, minimally invasive sensor systems capable of continuously monitoring C-peptide levels as a marker of beta cell function in individuals with type 1 diabetes (T1D). This funding call supports early-stage technology development, preclinical validation, and feasibility studies for clinical applications. Projects should demonstrate strong innovation, scalability, and alignment with the needs of therapeutic development for T1D, including integration with existing CGM platforms or other user-friendly formats.

• Geographies: Global.

• Who can apply: Research institutions, academic centers, and non-profits globally; PIs must hold a PhD/MD and an institutional appointment.

• Funding amount: Up to USD $900,000 over 3 years.

• Targeted Sectors / SDGs: Health; Focus areas: T1D diagnostics, biosensor development, beta cell therapies, real-time disease monitoring.

• Deadline: December 4, 2025 (LOI); February 12, 2026 (Full Proposal).

• Learn more and apply here.

Continuous beta cell monitoring could transform how T1D progression is tracked and how therapies are tested, accelerating both science and clinical care.

RARE Grant Program – Research Accelerating RUNX1 Exploration (2026), Alex’s Lemonade Stand Foundation. *Closing soon!*

This two-year grant supports research that accelerates drug discovery and cancer prevention for individuals with RUNX1-FPD, a rare heritable blood cancer predisposition. Jointly funded with the RUNX1 Research Program, the grant seeks mechanistic, translational research that targets early intervention strategies—including clonal hematopoiesis and inflammatory evasion. Projects should emphasize clinical relevance and collaborations, and will be showcased annually at the RUNX1 scientific conference.

• Geographies: Global..

• Who can apply: MD/PhD researchers at nonprofit institutions with experience in hematopoiesis or immunology.

• Funding amount: USD $250,000 over 2 years (max $125,000/year).

• Targeted Sectors / SDGs: Health / Wellbeing; Focus areas: RUNX1-FPD, clonal hematopoiesis, blood cancer prevention.

• Deadline: December 11, 2025 (8:00 PM Eastern Time).

• Learn more and apply here.

This fund bridges rare disease research with translational oncology to intercept cancer before it begins.

2026 Clostridioides difficile Research Collaboration RFP, Pfizer. *Closing soon!*

Pfizer is soliciting letters of intent for non-interventional research studies that assess the disease burden of Clostridioides difficile (C. difficile) in adults, especially healthy individuals over 50 and high-risk adults aged 18–49. Projects may be population-based or hospital-based (inpatient or outpatient) and must involve confirmed CDI testing. Studies are expected to generate epidemiological evidence to inform public health responses, with selected investigators invited to co-develop the research in partnership with Pfizer under a formal collaboration agreement.

• Geographies: United States, United Kingdom, France, Germany, Japan.

• Who can apply: Institutions in eligible countries; PIs must hold medical, postdoctoral, or advanced health science degrees.

• Funding amount: Up to USD $500,000 per study.

• Targeted Sectors / SDGs: Primary Sector: Infectious disease; Focus areas: C. difficile, disease burden, public health surveillance, adult infections.

• Deadline: December 11, 2025 (23:59 EST).

• Learn more and apply here.

This call centers burden estimation as a strategic lever for global antimicrobial stewardship and adult infection response.

Accelerating Innovation in Vaginal Formulations in Support of Women’s Health, Gates Foundation / Grand Challenges. *Closing soon!*

This call invites innovative proposals to develop vaginal formulations that deliver therapeutic or preventive agents while also supporting vaginal health, pleasure, or other user-defined benefits. Grants are available for projects that explore scalable, low-cost solutions tailored to LMIC contexts. Proposals may focus on novel delivery systems, enhancing the vaginal microbiome, or qualitative studies identifying desirable product characteristics. Submissions are coordinated through five parallel Grand Challenges platforms—Africa, Brazil, India, South Africa, and Gates Foundation global—each with its own eligibility rules and application portal. Applicants should apply through the platform aligned with their geography and institutional eligibility.

• Geographies: Global South, with portals for Brazil, India, South Africa, Africa, and international.

• Who can apply: Legally registered institutions including nonprofits, academic centers, companies, or research groups; emphasis on LMIC- and women-led teams.

• Funding amount: Grants range USD $100,000 - $250,000 per project; smaller, riskier proposals encouraged.

• Targeted Sectors / SDGs: Health; Focus areas: vaginal delivery systems, female-centered product innovation, reproductive autonomy.

• Deadline: December 16, 2025 (11:30 AM Pacific Time).

• Learn more and apply here.

This opportunity emphasizes delivery systems that are not just effective- but desirable, acceptable, and co-designed for the women who use them.

Accelerating Development of Innovative, Exceptionally Low-Cost Maternal and Child Nutrient Ingredients and Products, Gates Foundation / Grand Challenges. *Closing soon!*

This global call seeks transformative innovations to drastically reduce the cost of key prenatal and maternal-child nutrition products, specifically calcium, choline, and DHA. Applicants can apply under three funding tracks: (A) development of ultra low-cost pharmaceutical-grade ingredients, (B) low-cost prenatal supplements aligned with the UNIMMAP standard, or (C) advanced multi-nutrient formulations including DHA and choline. Each track has cost-reduction targets and stability requirements. Proposals must demonstrate technical feasibility, scalability, and alignment with the needs of LMICs, especially where production capacity and cost remain barriers to access.

• Geographies: Global.

• Who can apply: Registered nonprofits, companies, academic institutions, and government agencies; LMIC partnerships strongly encouraged.

• Funding amount: USD $200,000–500,000 depending on track.

• Targeted Sectors / SDGs: Health; Focus areas: nutrient ingredient innovation, maternal-child supplementation, prenatal health.

• Deadline: December 16, 2025 (11:30 AM Pacific Time).

• Learn more and apply here.

This call targets upstream innovation to address the cost bottlenecks that make essential maternal nutrition products unaffordable in low-resource settings.

Implementation Research for Strengthening Diabetes and Hypertension Care in Ghana, Alliance for Health Policy and Systems Research (WHO). *New!* *Closing soon!*

The WHO Country Office in Ghana and the Alliance for Health Policy and Systems Research invite proposals for embedded implementation research to evaluate the integration of WHO PEN protocols and the NCD e-tracker digital tool into primary health care for diabetes and hypertension. The selected Ghana-based research team will assess outcomes related to screening, diagnosis, and treatment in rural PHC facilities, while examining feasibility and adoption of the e-tracker. The 12-month research will inform Ghana’s national strategy for NCDs and contribute to regional and global learnings on scaling digital health for chronic care in LMICs. Findings must yield actionable policy outputs, include strong gender representation, and foster real-time collaboration with the Ghana Health Service.

• Geographies: Ghana.

• Who can apply: Ghana-based research institutions; must include one Ghana Health Service policy-maker or implementer.

• Funding amount: USD $100,000 for one project.

• Targeted Sectors / SDGs: Scientific Research; Focus areas: diabetes, e-tracker, PHC innovation, hypertension.

• Deadline: December 17, 2025.

• Learn more and apply here.

Proposals that actively embed within health system structures, with Ghana Health Service involvement and policy translation outputs, will strongly align with WHO expectations.

One Health Training on Quality Improvement in IPC and AMS, ICARS. *New!* *Closing soon!*

This regional call supports the design and delivery of bilingual training to strengthen quality improvement for infection prevention and antimicrobial stewardship across One Health systems in Africa. ICARS seeks multidisciplinary consortia to lead a three-year program combining in-person and virtual components, focused on practical implementation, mentorship, and systems-wide capacity strengthening across human and animal health sectors.

• Geographies: African LMICs.

• Who can apply: Lead institution must be based in, or partnered with, an African LMIC; consortia encouraged.

• Funding amount: Up to USD $300,000.

• Targeted Sectors / SDGs: Scientific Research; Focus areas: antimicrobial stewardship, infection prevention, quality improvement.

• Deadline: December 17, 2025.

• Learn more and apply here.

This call is about sustainable implementation. Proposals must demonstrate deep systems integration and frontline ownership to deliver lasting impact.

Charity Grants – Round 2, 1001 Critical Days Foundation. *New!* *Closing soon!*

The 1001 Critical Days Foundation provides long-term grants to UK-based charities advancing support for babies from pregnancy through age two. Rooted in a deep commitment to the importance of early childhood, the foundation funds projects delivered through family hubs- community-based “one stop shops” offering accessible and stigma-free services. Projects may focus on infant feeding, perinatal mental health, parenting, speech and language development, or strengthening parent-infant relationships. Priority is given to interventions with measurable impact, long-term sustainability, and co-funding already in place.

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 23 open opportunities- 18 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 7 rolling opportunities- - 1 new!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 6 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Crazy 8 Initiative Grant – Pediatric Brain Tumors (2026), Alex’s Lemonade Stand Foundation. *New!* *Closing soon!*

This high-impact research grant supports consortia developing novel, less toxic therapies for pediatric brain and spinal cord tumors. Building on ALSF’s global Crazy 8 Initiative, the 2026 cycle targets innovative solutions to overcome barriers such as blood-brain barrier penetration, toxicity of treatments, and insufficient preclinical models. Multidisciplinary teams are expected to collaborate across institutions and may include patient advocates. Projects are judged on innovation, translational potential, and contribution to long-term cancer cures.

• Geographies: Global.

• Who can apply: MD/PhD-level PIs at nonprofit academic institutions worldwide.

• Funding amount: USD $3 - $5M over 4 years.

• Targeted Sectors / SDGs: Health / Wellbeing; Focus areas: Pediatric brain tumors, blood-brain barrier, preclinical modeling.

• Deadline: November 5, 2025 (LOI); April 28, 2026 (Full proposal).

• Learn more and apply here.

This fund catalyzes large-scale, cross-institutional breakthroughs in pediatric neuro-oncology.

Mental Health Award: Transforming early intervention, Wellcome Trust. *Closing soon!*

Wellcome Trust seeks to catalyze research that transforms early-stage mental health intervention for anxiety, depression, and psychosis in young people. The two-phase award starts with a Foundation Phase (£200,000) to co-design and plan interventions with economic evaluation and implementation frameworks, followed by an Impact Phase (£5–8 million) to rigorously test real-world effectiveness. The fund requires embedded lived experience and implementation partners to ensure interventions are designed and delivered with contextual relevance.

• Geographies: Global (research conducted in UK and LMICs).

• Who can apply: Established researchers leading interdisciplinary teams, including mental health, health economics, and implementation expertise.

• Funding amount: Foundation Phase: £200,000; Impact Phase: £5–8 million.

• Targeted Sectors / SDGs: Mental Health Science; Early Intervention.

• Deadline: November 11, 2025.

• Learn more and apply here.

This award signals Wellcome’s strategic intent to shift from understanding mental health to intervening earlier, with both scientific rigor and equity built into the design from the start.

2025 ONC US MIBC Emerging Data IME, Pfizer. *New!* *Closing soon!*

Inviting proposals for independent medical education initiatives that address key knowledge gaps in the treatment of muscle-invasive bladder cancer (MIBC). The RFP focuses on educational strategies that spotlight unmet clinical needs, advance understanding of perioperative therapies, and disseminate insights on emerging treatments such as antibody-drug conjugates. Proposals should target multidisciplinary teams and emphasize practice change through improved communication, coordination of care, and patient-centered decision-making.

• Geographies: United States.

• Who can apply: Accredited medical schools, healthcare institutions, professional societies, and other qualified US-based organizations.

• Funding amount: USD $10,000–$220,000 (total pool: $500,000).

• Targeted Sectors / SDGs: Primary Sector: Health; Focus areas: bladder cancer, MIBC education, perioperative treatment, ADCs.

• Deadline: November 12, 2025 (23:59 EST).

• Learn more and apply here.

This initiative advances medical literacy in fast-evolving oncology landscapes, targeting real-world practice improvements.

HIV-Instrument 2026–2030 – Southern Africa, Ministry of Foreign Affairs of the Netherlands. *New!* *Closing soon!*

This €98.7 million initiative aims to end HIV/AIDS as a public health threat in Southern Africa by empowering regional civil society organizations to lead inclusive, evidence-based, and locally anchored HIV responses. The fund is structured in two parts: Stream 1 (€83.7M) directly supports implementation by regional CSOs; Stream 2 (€15M), managed by Aidsfonds, strengthens technical and organizational capacity and ensures alignment with Dutch localization principles. All applicants must propose multi-country, multi-stakeholder strategies that address both service delivery and policy change, targeting adolescent girls, young women, and key populations.

• Geographies: Angola, Eswatini, Mozambique, South Africa, Zambia, Zimbabwe, and border areas of Lesotho and Malawi.

• Who can apply: Regional CSOs as leads; local CSOs as partners; international NGOs and UN entities not eligible.

• Funding amount: EUR €15M–83.7M (total pool: €98.7M).

• Targeted Sectors / SDGs: Health; Focus areas: HIV response, adolescent girls & young women, key populations, systems strengthening.

• Deadline: Concept notes due November 15, 2025 (23:59 Maputo time).

• Learn more and apply here.

The fund reflects a major shift in Dutch development cooperation toward regional leadership and health systems transformation.

Top Up Community Grants 2026, Mental Health Foundation of New Zealand. *New!* *Closing soon!*

These grants fund community-led wellbeing initiatives across Aotearoa that align with the Five Ways to Wellbeing: Connect, Give, Take Notice, Be Active, and Keep Learning. With a strong equity lens, the fund prioritizes support for Māori, Pasifika, youth, rainbow, disabled, rural, and Asian communities. Projects must reflect the cultural strengths and aspirations of the people they serve, and demonstrate potential for long-term impact. This fund invites a wide range of applicants so long as they foster sustainable, everyday wellbeing practices.

• Geographies: New Zealand.

• Who can apply: Community orgs, informal groups, iwi, marae, schools, charities, clubs, and faith-based groups.

• Funding amount: Grants range NZD $10,000–40,000 per project..

• Targeted Sectors / SDGs: Health / Wellbeing; Focus areas: Five Ways to Wellbeing, Māori wellbeing, inclusive mental health.

• Deadline: November 16, 2025 (23:59 New Zealand Time).

• Learn more and apply here.

This grant champions culturally grounded, community-driven approaches to mental wellbeing equity.

Wellcome Career Development Awards, Wellcome. *Closing soon!*

Wellcome is strengthening the next generation of global research leadership through long-term funding for mid-career scientists with bold, independent research visions. This scheme prioritizes researchers with a compelling vision and interdisciplinary ambition, offering long-term funding that supports scientific freedom, leadership growth, and career sustainability. It’s part of Wellcome’s broader strategy to strengthen research ecosystems and promote equity in global health.

• Geographies: UK, Republic of Ireland, LMICs (excluding India and mainland China).

• Who can apply: Mid-career researchers with a PhD and postdoctoral experience; not yet leading their own research group.

• Funding amount: Typically under £250,000/year (excluding salary), for up to 8 years.

• Targeted Sectors / SDGs: Health, Science and Technology, Education — SDG 3, SDG 4, SDG 9.

• Deadline: November 20, 2025. Three windows annually, following window will be in March 2026.

• Learn more and apply here.

This is Wellcome’s flagship pipeline for emerging global research leadership across disciplines, and a fantastic opportunity for LMIC- and UK-based mid-career researchers to secure deep, flexible funding to lead their next big idea.

Combination Therapies for Parkinson’s: 2025 Call, Cure Parkinson’s. *New!* *Closing soon!*

Cure Parkinson’s is inviting applications for drug-based combination therapies aimed at disease modification in Parkinson’s. Projects should test two or more agents with strong mechanistic rationale, categorized as congruous, syncretic, or coalistic, supported by robust preclinical or clinical data. Both novel and repurposed combinations are eligible. All projects must involve milestones, and priority will be given to those with potential for clinical translation within five years. Public involvement, particularly from people with Parkinson’s, is central to evaluation.

• Geographies: Global.

• Who can apply: Academia and industry, individually or in partnership.

• Funding amount: ~£300,000 (preclinical); ~£1 million (clinical); Total pool: £2M.

• Targeted Sectors / SDGs: Health; Focus areas: Parkinson’s, neurodegeneration, drug combinations.

• Deadline: November 24, 2025 (EOI); January 26, 2026 (Full).

• Learn more and apply here.

The fund prioritizes drug combinations likely to reach clinical application in the near term.

COLLABORATE Grant Program: Supporting Aging Adults Living with Rare Diseases, Pfizer. *New!* *Closing soon!*

Seeks to supports organizations working to improve the lives of aging adults with rare diseases through education, policy advocacy, and systems-level analysis. Funded projects may focus on advancing national action plans, reducing misdiagnosis through professional awareness, and closing gaps in healthcare access and policy. Proposals should demonstrate measurable impact, alignment with advocacy outcomes, and the ability to engage in a learning cohort facilitated by CanAge.

• Geographies: Global.

• Who can apply: Health professional schools, healthcare institutions, patient advocacy groups, and nonprofits; only organizations are eligible.

• Funding amount: Up to USD $25,000 per project; total pool USD $100,000.

• Targeted Sectors / SDGs: Primary Sector: Health systems strengthening; Focus areas: rare disease in aging, policy advocacy, awareness-building, care gaps.

• Deadline: November 24, 2025 (23:59 EST).

• Learn more and apply here.

This fund highlights a growing need to adapt rare disease strategies to the realities of aging populations, especially where ageism, policy gaps, and late diagnosis intersect.

Gut Microbiota International Call for Projects, Biocodex Microbiota Foundation. *Closing soon!*

The Biocodex Microbiota Foundation founds research projects focused on human gut microbiota related to health and disease. The focus this year is on Resilience of the gut microbiome following perturbations and their implications to human health and disease. Perturbations (of the gut microbiome) may involve, but not exclusively, drugs, life styles factors, smoking. The project should address mechanisms. Funding should not be used for a randomized controlled trial but can include the use/ analysis of samples collected from clinical trials. Either clinical or fundamental research proposals can be submitted.

• Geographies: Global.

• Who can apply: PhD's and Pharm-D's working in the subject area (gastroenterology, pediatrics, microbiology, infectious diseases and internal medicine, etc) within universities, hospitals or other research settings.

• Funding amount: Grant of up to €200,000 over 1 or 3 years.

• Targeted Sectors/ SDGs: Health, research.

• Deadline: November 30, 2025.

• Learn more and apply here.

Small Grants for Community WASH Projects in Asia & Oceania, Luena Foundation. *New!*

Luena Foundation is offering microgrants to support locally led, community-based initiatives that enhance access to safe water, sanitation, and hygiene in Asia and Oceania. This call targets small-scale, high-impact projects serving vulnerable children and families—especially in rural and under-resourced settings. Projects might include borehole repair, latrine construction, school hygiene programs, or innovative purification solutions. Applicants must be local nonprofits with boards and staff from the communities they serve and must contribute 25% of project costs via cash, labor, or materials.

• Geographies: Cambodia, Laos, Vietnam, Myanmar, Thailand, Malaysia, Bhutan, Indonesia, Philippines, Timor-Leste, Nepal, Bangladesh, India, Sri Lanka, Pakistan, Kyrgyzstan, Tajikistan, Mongolia, Papua New Guinea, Fiji, Solomon Islands, Vanuatu, Samoa, Tonga, Kiribati, Tuvalu, Micronesia (FSM, Palau, Marshall Islands, Nauru).

• Who can apply: Locally led, registered nonprofit or community-based organizations.

• Funding amount: Grants range USD $1,000 - $1,500.

• Targeted Sectors / SDGs: Water & Sanitation; Focus areas: safe water access, hygiene, child health.

• Deadline: December 1, 2025 (Local Time).

• Learn more and apply here.

These small but catalytic grants aim to enable community-driven solutions in settings where WASH gaps are greatest.

RARE Grant Program – Research Accelerating RUNX1 Exploration (2026), Alex’s Lemonade Stand Foundation. *New!*

This two-year grant supports research that accelerates drug discovery and cancer prevention for individuals with RUNX1-FPD, a rare heritable blood cancer predisposition. Jointly funded with the RUNX1 Research Program, the grant seeks mechanistic, translational research that targets early intervention strategies—including clonal hematopoiesis and inflammatory evasion. Projects should emphasize clinical relevance and collaborations, and will be showcased annually at the RUNX1 scientific conference.

• Geographies: Global..

• Who can apply: MD/PhD researchers at nonprofit institutions with experience in hematopoiesis or immunology.

• Funding amount: USD $250,000 over 2 years (max $125,000/year).

• Targeted Sectors / SDGs: Health / Wellbeing; Focus areas: RUNX1-FPD, clonal hematopoiesis, blood cancer prevention.

• Deadline: December 11, 2025 (8:00 PM Eastern Time).

• Learn more and apply here.

This fund bridges rare disease research with translational oncology to intercept cancer before it begins.

2026 Clostridioides difficile Research Collaboration RFP, Pfizer. *New!*

Pfizer is soliciting letters of intent for non-interventional research studies that assess the disease burden of Clostridioides difficile (C. difficile) in adults, especially healthy individuals over 50 and high-risk adults aged 18–49. Projects may be population-based or hospital-based (inpatient or outpatient) and must involve confirmed CDI testing. Studies are expected to generate epidemiological evidence to inform public health responses, with selected investigators invited to co-develop the research in partnership with Pfizer under a formal collaboration agreement.

• Geographies: United States, United Kingdom, France, Germany, Japan.

• Who can apply: Institutions in eligible countries; PIs must hold medical, postdoctoral, or advanced health science degrees.

• Funding amount: Up to USD $500,000 per study.

• Targeted Sectors / SDGs: Primary Sector: Infectious disease; Focus areas: C. difficile, disease burden, public health surveillance, adult infections.

• Deadline: December 11, 2025 (23:59 EST).

• Learn more and apply here.

This call centers burden estimation as a strategic lever for global antimicrobial stewardship and adult infection response.

Accelerating Innovation in Vaginal Formulations in Support of Women’s Health, Gates Foundation / Grand Challenges. *New!*

This call invites innovative proposals to develop vaginal formulations that deliver therapeutic or preventive agents while also supporting vaginal health, pleasure, or other user-defined benefits. Grants are available for projects that explore scalable, low-cost solutions tailored to LMIC contexts. Proposals may focus on novel delivery systems, enhancing the vaginal microbiome, or qualitative studies identifying desirable product characteristics. Submissions are coordinated through five parallel Grand Challenges platforms—Africa, Brazil, India, South Africa, and Gates Foundation global—each with its own eligibility rules and application portal. Applicants should apply through the platform aligned with their geography and institutional eligibility.

• Geographies: Global South, with portals for Brazil, India, South Africa, Africa, and international.

• Who can apply: Legally registered institutions including nonprofits, academic centers, companies, or research groups; emphasis on LMIC- and women-led teams.

• Funding amount: Grants range USD $100,000 - $250,000 per project; smaller, riskier proposals encouraged.

• Targeted Sectors / SDGs: Health; Focus areas: vaginal delivery systems, female-centered product innovation, reproductive autonomy.

• Deadline: December 16, 2025 (11:30 AM Pacific Time).

• Learn more and apply here.

This opportunity emphasizes delivery systems that are not just effective- but desirable, acceptable, and co-designed for the women who use them.

Accelerating Development of Innovative, Exceptionally Low-Cost Maternal and Child Nutrient Ingredients and Products, Gates Foundation / Grand Challenges. *New!*

This global call seeks transformative innovations to drastically reduce the cost of key prenatal and maternal-child nutrition products, specifically calcium, choline, and DHA. Applicants can apply under three funding tracks: (A) development of ultra low-cost pharmaceutical-grade ingredients, (B) low-cost prenatal supplements aligned with the UNIMMAP standard, or (C) advanced multi-nutrient formulations including DHA and choline. Each track has cost-reduction targets and stability requirements. Proposals must demonstrate technical feasibility, scalability, and alignment with the needs of LMICs, especially where production capacity and cost remain barriers to access.

• Geographies: Global.

• Who can apply: Registered nonprofits, companies, academic institutions, and government agencies; LMIC partnerships strongly encouraged.

• Funding amount: USD $200,000–500,000 depending on track.

• Targeted Sectors / SDGs: Health; Focus areas: nutrient ingredient innovation, maternal-child supplementation, prenatal health.

• Deadline: December 16, 2025 (11:30 AM Pacific Time).

• Learn more and apply here.

This call targets upstream innovation to address the cost bottlenecks that make essential maternal nutrition products unaffordable in low-resource settings.

HealthPro2 Grant Program – Sudan, Agenzia Italiana per la Cooperazione allo Sviluppo (AICS). *New!*

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 26 open opportunities- 15 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 6 rolling opportunities!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 9 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Call for Innovations: CMD Management & Prevention in Humanitarian Settings, Elrha. *New!* *Closing soon!*

Elrha, in partnership with the Novo Nordisk Foundation and the African Population and Health Research Center (APHRC), is seeking examples of innovative approaches to managing and preventing cardiometabolic diseases (CMDs), such as diabetes, hypertension, and cardiovascular emergencies, in humanitarian and fragile settings across Sub-Saharan Africa. This is not a funding call. Rather, selected innovations will be featured in global research outputs, videos, and policy briefs, and innovators may be invited to a high-level convening. The goal is to spotlight actionable models, surface under-recognized work, and support peer learning and policy influence in a highly underfunded health space.

• Geographies: Sub-Saharan Africa.

• Who can apply: NGOs, researchers, health actors, community groups, policymakers — any entity or individual with a documented innovation implemented in the past 6 years.

• Funding amount: No direct funding; recognition and convening opportunities only.

• Targeted Sectors / SDGs: Non-Communicable Diseases; Focus areas: CMDs, diabetes, humanitarian innovation, fragile settings, community-led models.

• Deadline: October 3, 2025.

• Learn more and apply here.

While not a funding round, this is a rare chance to elevate community-driven solutions for non-communicable diseases in fragile contexts and get on the radar of major actors shaping global health investments.

Livestock and Communities for One Health in the Mekong (LIVECOM), International Fund for Agricultural Development (IFAD). *New!* *Closing soon!*

This two-year initiative will support efforts to operationalize the One Health approach across four countries in Southeast Asia. By linking animal, human, and environmental health, LIVECOM seeks to enhance community-level preparedness for zoonotic disease, antimicrobial resistance, and environmental degradation. The program will support mapping of One Health risks, establish or strengthen multisector platforms, pilot field initiatives, and produce regional knowledge products. With strong inclusivity targets and direct links to existing IFAD programs, the initiative emphasizes local capacity, evidence-based policy engagement, and cross-country learning to strengthen health security systems in rural areas.

• Geographies: Cambodia, Lao PDR, Thailand, Viet Nam.

• Who can apply: Registered NGOs, international NGOs, multilateral organizations, or research/academic institutions with ≥5 years’ experience in One Health, rural development, and community engagement.

• Funding amount: USD $1,000,000; co-financing required (20–25%).

• Targeted Sectors / SDGs: Public Health / One Health; Focus areas: zoonotic disease, AMR, food safety, community-based surveillance, risk mapping.

• Deadline: October 6, 2025 (23:59 UTC+2).

• Learn more and apply here.

LIVECOM leverages IFAD’s rural reach to bring systemic One Health action to the communities most affected by converging health risks.

Perception Box RFP – Tiny Blue Dot Foundation, Tiny Blue Dot Foundation. *New!* *Closing soon!*

The Tiny Blue Dot Foundation is issuing an open Request for Proposals to fund rigorous neuroscience and psychological research around its “Perception Box” concept. Applicants can propose interventions, measurement tools, and methods to expand how people perceive their internal and external worlds. The call employs a two-stage process (LOI then full proposal) and offers large multi-year awards.

• Geographies: Global (excluding sanctioned countries).

• Who can apply: 501(c)(3) research organizations, academic institutions, nonprofits, globally.

• Funding amount: Up to USD $900,000 over three years (≤ 15% overhead).

• Targeted Sectors / SDGs: Neuroscience / Psychology; Focus areas: perception expansion, youth mental health, intervention science, consciousness.

• Deadline: October 7, 2025 (11:59 PM PDT for LOI).

• Learn more and apply here.

This RFP invites bold empirical experimentation to reshape how we understand consciousness and perception as tools for mental health transformation.

Dedicated Action to Reinforcing Hospitals and Healthcare Providers (cybersecurity), European Commission (EC). *Closing soon!*

This action aims to strengthen the cybersecurity of hospitals and healthcare providers. The goal is to ensure that hospitals and healthcare providers, which are crucial operators in the health sector, can effectively detect, monitor, and respond to cyber threats, particularly ransomware, which pose significant risks, thereby enhancing the resilience of the European healthcare system. The action will support pilot projects, which will bring together stakeholders such as regional and/or national clusters associations of hospitals and healthcare providers (such as national healthcare systems, hospitals or associations of hospitals, healthcare providers and/or professional associations of healthcare practitioners), as well as cybersecurity service providers. Project outcomes should include; 1. Mapping of common cybersecurity needs of hospitals and healthcare providers; 2. Guidelines for healthcare providers to assess their current state of cybersecurity protection and relevant needs; 3. Technical cybersecurity plans to enhance preparedness and cyber resilience: improved detection and response capabilities for healthcare institutions minimizing the impact of cyberattacks, particularly for ransomware. This also includes dedicated training courses to staff; 4. Pilot cybersecurity demo installations at partner hospitals and healthcare provider sites to ensure hospitals and healthcare providers can maintain operational continuity in the face of cybersecurity incidents. This should be monitored through specific KPIs; 5. Wide dissemination campaigns to help scale up preparedness of hospitals and healthcare providers in Europe.

• Geographies: EU Member States (including overseas countries and territories (OCTs), and EEA countries (Norway, Iceland, Liechtenstein).

• Who can apply: Public and private legal entities.

• Funding amount: Total funding available EUR €30M.

• Targeted Sectors/ SDGs: Health care, cybersecurity.

• Deadline: October 7, 2025.

• Learn more and apply here.

Challenge Programme 2026: Modelling Human Cardiometabolic Disease, Novo Nordisk Foundation. *Closing soon!*

The Challenge Program aims to contribute substantially to the development of Danish and European research ecosystems within research areas of strategic priority to the Novo Nordisk Foundation. The goal is to develop innovative solutions to major scientific challenges, supporting leading researchers to form a consortium united by a clear vision and mission. The Program provides funding to enable scientific depth and focus and facilitate synergy between the research partners. For the 2026 application call, the Challenge Program is seeking to support the following research theme: Modelling of Human Cardiometabolic Disease. The Challenge is to develop one or more novel human CMD model(s), preclinical, clinical, computational or a combination hereof, with sufficient characterization and validation to demonstrate that the model(s) reflects the intricate mechanisms and multifactorial nature of these conditions better than current models. Specifically, model validation should include testing of predefined CMD drugs to ensure improved translation of basic research findings into the clinic. Also, the ideal disease model(s) considers the diversity of the human population to enhance the understanding of how genetic backgrounds, including factors like ethnicity and sex differences, contribute to disease.

• Geographies: Europe.

• Who can apply: Collaboration between leading scientific experts to form a consortium of 2-4 research groups (main applicant plus 1-3 co-applicants). The main applicant must be an independent tenured/tenure-track researcher with their own research group, employed at a European (European Union, Schengen Area plus United Kingdom) university, hospital, or non-profit research organization, which will be the host institution and will be responsible for administration of the grant.

• Funding amount: A total budget of up to DKK 150 million (ca. EUR 20 million) is available for grants of DKK 40 – 75 million (ca. EUR 5,4 – 10 million) for projects of 6 years duration.

• Targeted Sectors/ SDGs: Health, cardiometabolic Disease, research.

• Deadline: October 8, 2025.

• Learn more and apply here.

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 38 open opportunities- 12 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 6 rolling opportunities- 1 new!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

GSK Africa Open Lab 2025 Call for Proposals, GSK Africa Open Lab (GSK Supported Studies). *New!* *Closing soon!*

GSK invites early career African scientists to lead locally rooted infectious disease research through its Africa Open Lab 2025 call. The initiative seeks proposals targeting malaria, drug-resistant TB, antimicrobial resistance, and enteric infections, offering up to £100,000 per award, alongside mentorship, training, and scientific support. The two-stage review process ensures both the concept and execution are rigorously developed and contextually relevant.

• Geographies: Sub‑Saharan Africa.

• Who can apply: Early career African PIs (≤5 years post-degree), based at SSA research institutions.

• Funding amount: Up to GBP £100,000 per award.

• Targeted Sectors / SDGs: Infectious Disease Research, Early-Career Capacity Building — SDG 3, SDG 9, SDG 17.

• Deadline: September 3, 2025 (17:00 GMT).

• Learn more and apply here.

Fondo Región Plateada – Call for Proposals 2, Fondo Región Plateada (IDB Lab, Fundación Arturo Sesana, IDRC, GRADE). *New!* *Closing soon!*

The Fondo Región Plateada, a joint initiative to strengthen the care economy in Latin America and the Caribbean, has launched its second call to support enterprises developing innovative, inclusive solutions for aging populations. The call targets businesses that can expand access to elder care services, build robust caregiver training systems, and create tools to prevent dependency and promote autonomy among people over 60. Selected companies will participate in a structured three-phase process: an initial diagnostic and mapping stage, a 12-week acceleration program, and finally, financing opportunities to scale their solutions.

• Geographies: Latin America and the Caribbean.

• Who can apply: For-profit entities legally incorporated for ≥1 year with revenues in past year; must already be operating in at least one market; non-LAC applicants must establish a local presence or partner.

• Funding amount: Up to USD $100,000 per initiative (financing phase).

• Targeted Sectors / SDGs: Health, Social Protection, Innovation, Entrepreneurship.

• Deadline: September 7, 2025.

• Learn more and apply here.

This fund is one of the first regional vehicles explicitly investing in the silver economy, aiming to scale solutions for dignified and inclusive aging in LAC.

Drivers of Health RFP, Physicians Foundation. *New!* *Closing soon!*

The Physicians Foundation is seeking proposals from U.S. medical associations to strengthen physician capacity to address the social and environmental conditions that shape patient health. This call focuses on integrating Drivers of Health (DOH) including; food insecurity, housing instability, transportation barriers, utility challenges, and safety concerns. Selected grantees will recruit physicians to pilot DOH screenings and resource navigation, develop resource guides, and share insights through a national peer-learning platform. With projects lasting one to two years, this RFP emphasizes approaches that are timely, field-driven, and strategically positioned to advance physician-led health equity.

• Geographies: United States.

• Who can apply: U.S.-based nonprofit medical associations and foundations with demonstrated physician engagement capacity/

• Funding amount: Up to $75,000 per project (five awards available) for 1–2 year implementation.

• Targeted Sectors / SDGs: Health, Capacity Building, Research.

• Deadline: September 8, 2025.

• Learn more and apply here.

This program represents a significant investment in equipping physician networks to tackle the root causes of health inequities through practice-level innovation.

Powering Healthcare (PHC) Innovation Fund – Round 2, Sustainable Energy for All (SEforALL) / UNOPS. *New!* *Closing soon!*

This second round of the PHC Innovation Fund seeks bold, replicable solutions to transform how healthcare facilities are electrified in low-income contexts. Targeting 12 countries in Sub-Saharan Africa, the Fund supports innovations that go beyond business-as-usual—whether through new financing models, operations and maintenance frameworks, capacity building, data and AI-enabled insights, or research. Projects must be catalytic, with the potential to scale across regions, and should directly enhance healthcare service delivery by improving reliable energy access. Infrastructure installation is excluded; instead, the focus is on ideas that can shift the sector toward long-term sustainability.

• Geographies: DRC; Ghana; Kenya; Madagascar; Malawi; Mozambique; Nigeria; Rwanda; Sierra Leone; Tanzania; Uganda; Zambia.

• Who can apply: NGOs, foundations, CSOs, academic/research institutions, for-profit entities legally registered ≥3 years in an eligible country; must have managed ≥2 similar-value projects; 30% co-financing required.

• Funding amount: Up to USD $80,000 per grantee; total USD $300,000 for 3 - 6 grantees.

• Targeted Sectors / SDGs: Sustainable Energy; Healthcare; Innovation; Data Systems.

• Deadline: September 8, 2025 (17:00 Central European Summer Time).

• Learn more and apply here.

Discovery Research Grants, March of Dimes. *Closing soon!*

These grants are awarded to seasoned researchers seeking to make consequential translational discoveries that will drastically alter clinical care for pregnant people and babies, whether through evidence-based prevention, diagnosis, or intervention, and drastically improve pregnancy and birth outcomes across the US. Discovery Grants are funding vehicles for research inquiries that are as practical as they are ambitious, as attainable as they are groundbreaking, and as transformative as they are necessary. The proposed research should focus on one of these priority topic areas: 1. Spontaneous preterm birth, 2. Decreasing Maternal and Infant Morbidity and Mortality by Improving Access to High Quality Health Care, 3. Cardiovascular health conditions developed during pregnancy or exacerbated during pregnancy.

• Geographies: USA (The award is open to global applicants).

• Who can apply: Health professionals, health researchers, epidemiologists, and social scientists with doctoral academic degrees and either a faculty appointment or equivalent at academic universities, hospitals, and research institutions; from those who are employees of small businesses, startup companies, non-profit organizations, or pharmaceutical companies committed to research in the area of maternal and infant health.

• Funding amount: Grant of up to $200,000 over two years inclusive of 10% indirect costs.

• Targeted Sectors/ SDGs: Health, Maternal and Infant health morbidity and mortality.

• Deadline: September 8, 2025.

• Learn more and apply here.

2025 Call for Synergistic Initiatives under the Global Fund 5% Mechanism, Italian Agency for Development Cooperation (AICS). *New!* *Closing soon!*

AICS is calling for Italian-led projects that align with the Global Fund’s 2023–2028 strategy to combat AIDS, tuberculosis, and malaria while strengthening inclusive, people-centered health systems. With €3.1M available under Italy’s 5% technical support allocation, this funding stream is designed to catalyze cross-sector collaboration and amplify the leadership of communities most affected by these diseases. Proposals must be implemented in priority Sub-Saharan countries and demonstrate strong local partnerships.

• Geographies: Italy, Angola, Burkina Faso, Cameroon, Central African Republic, DRC, Ethiopia, Guinea, Kenya, Malawi, Mozambique, Senegal, Sierra Leone, Somalia, Sudan, South Sudan, Tanzania, Uganda.

• Who can apply: Italian CSOs, public research institutions, and universities partnering across sectors.

• Funding amount: Up to EUR €775,000 per project; total pool: €3.1M

• Targeted Sectors / SDGs: Health, Governance, Research, SDG 3, SDG 5, SDG 10.

• Deadline: September 9, 2025 (12:00 Rome Time).

• Learn more and apply here.

Research Grants in Open Competition, Leo Foundation. *New!* *Closing soon!*

The Leo Foundation seeks to advance global dermatological research by funding investigator-led projects that deepen scientific understanding of skin biology and disease mechanisms. This open competition supports basic, translational, epidemiological, and clinical research, with a clear preference for non-commercial, impact-driven initiatives. Exclusions apply for projects on skin cancer and aesthetic dermatology, aligning with the Foundation’s goal to fund high-integrity science with societal relevance.

• Geographies: Global.

• Who can apply: PhD-qualified researchers affiliated with universities, hospitals, or other non-profit institutions.

• Funding amount: DKK 2–4 million (~USD $290,000–580,000) for 1–3 years.

• Targeted Sectors / SDGs: Health, Science and Technology; SDG 3.

• Deadline: September 11, 2025 (16:00 CEST).

• Learn more and apply here.

AlzInsights Prize – Accelerating Alzheimer's Discovery with Agentic Intelligence, Alzheimer’s Disease Data Initiative (AD Data Initiative). *New!* *Closing soon!*

The AD Data Initiative, backed by Bill Gates and global partners, is launching the AlzInsights Prize, a global $1 million challenge to drive innovation in Alzheimer’s disease and related dementias (ADRD) research. This prize invites visionary teams in AI engineering, computational biomedicine, and ADRD biology to design autonomous agentic AI systems capable of planning, reasoning, and acting, that can unlock new scientific insights from existing Alzheimer’s data. Submissions must be compatible with AD Data Initiative platforms (e.g., AD Workbench), with pitched solutions designed for broad scientific impact and reuse.

• Geographies: Global.

• Who can apply: Multidisciplinary teams in AI and ADRD research.

• Funding amount: Prize of USD $1M.

• Targeted Sectors / SDGs: Scientific Research; Focus areas: agentic AI, autonomous systems, Alzheimer’s discovery, data-driven research.

• Deadline: September 12, 2025 (11:59 pm PT).

• Learn more and apply here.

By mobilizing autonomous AI to accelerate dementia research through open-data integration and global collaboration, this prize underscores the transformative role of agentic intelligence in advancing healthcare equity and discovery.

SPIE-Franz Hillenkamp Fellowship, SPIE. *Closing soon!*

One-year fellowship in biomedical optics. The SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics provides an annual award to translate new biomedical optics and biophotonics technologies to clinical practice for improving human health. Applicants and hosting labs must propose original research in biomedical optics that is expected to lead to new diagnostics and/or therapeutics in medicine and biology.

• Geographies: Global.

• Who can apply: Young investigators with a PhD, MD, or equivalent degree are eligible to apply.

• Funding amount: Award of USD $75,000.

• Targeted Sectors/ SDGs: Biomedical Optics.

• Deadline: September 15, 2025.

• Learn more and apply here.

Pioneer Innovator Grant-Health, Novo Nordisk Foundation. *Last window for 2025 closing soon!*

Seek to accelerate the commercialization of research findings and the development of novel technologies within health. The Pioneer Innovator Grant Health seeks to support innovative research within med-tech, industrial biotech, pharma as well as quantum technologies. Pioneer Innovator Grants seek to support novel academic science-based discoveries with commercial potential. The grant aims to stimulate the evaluation of ideas and to support experiments and activities leading to proof-of-concept or beyond.

• Geographies: Global.

• Who can apply: Lead applicant must be from a non-profit research institution in Denmark, Finland, Iceland, Norway, or Sweden. Co-applicants may come from the same hosting institution as the main applicant or from a different university, hospitals, or research institutions locally and abroad.

• Funding Amount: Grant of DKK 1.1 million per project.

• Targeted Sectors/ SDGs: Health, innovation.

• DEADLINE: September 15, 2025, 2:00pm Copenhagen time. This is a recurring call, next window expected to open January 2026.

• Learn more and apply here.

The Distinguished Innovator Grant-Health, Novo Nordisk Foundation. *Last window for 2025 closing soon!*

The purpose of the grant is to accelerate commercialization of research findings and development of novel technologies within health. The Distinguished Innovator Grant-Health seeks to support innovative research within med-tech, industrial biotech, pharma as well as quantum technologies. Furthermore, the intend is to stimulate the evaluation of ideas that for example could lead to the development of new medical treatment, disease prevention, diagnostic methods as well as new health technologies, devices and technological platforms. Particular focus will be placed on projects covering cardiometabolic diseases as well as infectious diseases and preventive solutions hereto. All applications must have a clear outlook to scaling potentials and later commercialization possibilities.

• Geographies: Global.

• Who can apply: Lead applicant must be from a non-profit research institution in Denmark, Finland, Iceland, Norway, or Sweden. Co-applicants may come from the same hosting institution as the main applicant or from a different university, hospitals, or research institutions locally and abroad.

• Funding Amount: Grant of DKK 6.8 million per project.

• Targeted Sectors/ SDGs: Health, innovation.

• DEADLINE: September 15, 2025, 2:00pm Copenhagen time. This is a recurring call, next window expected to open January 2026.

• Learn more and apply here.

Takeda Innovators in Science Award with Nature, Takeda and Nature. *Closing soon!*

Are looking for researchers with bold, innovative ideas that are in novel and potentially transformative lines of scientific discovery and research. The Takeda Innovators in Science Award with Nature honors groundbreaking research by early-career scientists in Gastrointestinal and Inflammatory Diseases, Neuroscience and Oncology. This global award recognizes researchers who are advancing the frontiers of scientific discovery, fostering innovation that has the potential to transform lives. The goal is to uplift emerging scientific leaders by providing them with the support and recognition needed to drive bold, transformative breakthroughs in their fields.

• Geographies: Global.

• Who can apply: Early-career researchers in academia or at a research institution who are advancing transformative research in Gastrointestinal and Inflammatory Diseases, Neuroscience and Oncology.

• Funding amount: Grand prize of USD $175,000. Awards of USD $75,000 to one winner from each category.

• Targeted Sectors/ SDGs:

• Deadline: September 16, 2025.

• Learn more and apply here.

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 40 open opportunities- 14 new!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 4 rolling opportunities!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 3 long term opportunities- 2 new!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Novo Nordisk Prize 2025, Novo Nordisk Foundation. *Closing soon!*

The Novo Nordisk Prize recognizes an active scientist who has provided outstanding international contributions to advance medical science for the benefit of people’s lives. The Prize is intended to award and further support biomedical research in Europe.

• Geographies: European based individuals.

• Who can apply: Nominees must have a current position and an active research program at a public, non-profit research institution and/or in a company based in a European country, but can be from any nationality.

• Funding amount: The Prize is of DKK 5 million (appr. EUR 672,000) and consists of a DKK 4,5 million (appr. EUR 605,000) research grant and a personal award of DKK 0,5 million (appr. EUR 67,000).

• Targeted Sectors/ SDGs: Health

• Deadline: August 1, 2025.

• Learn more and apply here.

Call for Nominations – The Novonesis Biotechnology Prize, Novo Nordisk Foundation. *Closing soon!*

The Novonesis Biotechnology Prize is awarded to recognize outstanding European research or technology achievements that contribute to the development of innovative and sustainable biotechnology solutions for the benefit of people and the planet.

• Geographies: Europe.

• Who can apply: Nominees must have made an important contribution to European Science in areas of relevance to e.g. biomanufacturing, industrial, environmental, food or plant biotechnology. Nominees must have a current position and an active research program at a public or non-profit research institution in a European country. Nominees can have any nationality.

• Funding amount: The Novonesis Biotechnology Prize consists of a funding amount for the awardee’s research (DKK 4.5 million) and a personal award (DKK 0.5 million). An additional an international symposium within the awardee’s field of research will be organized.

• Targeted Sectors/ SDGs: Health, research, biotechnology-based synthesis and production, industrial and environmental biotechnology.

• Deadline: August 1, 2026.

• Learn more and apply here.

Anticipatory call for proposals for research teams — Adolescents Thrive: African Adolescents Bolstered through Local Evidence (AABLE), International Development Research Centre. *Closing soon!*

IDRC’s Global Health division is launching this anticipatory call for select countries in Africa for implementation research projects to reduce knowledge gaps related to adolescent sexual and reproductive health (ASRH), strengthen capacities in implementation research and generate evidence to inform policymaking and promote innovative solutions tailored to the unique challenges faced by each country. AABLE aims to fund research to inform policies, practices and effective strategies to tackle specific challenges faced by adolescent girls and boys in meeting their sexual and reproductive health needs. It will generate quality evidence and identify priorities and strategies for addressing those challenges, including service constraints faced by health systems and the entrenched social and gender cultural norms that govern adolescents' lives.

• Geographies: Côte d'Ivoire, Ethiopia, Ghana, Kenya, Liberia, Malawi, Mozambique, Nigeria, Senegal, Sierra Leone, Tanzania, Zambia, Zimbabwe.

• Who can apply: A principal applicant/Principal Investigator (PI) who is a sub-Saharan Africa-based researcher (citizen or permanent resident of an African country) with a position in an institution based in one the priority countries where the research will take place.

• Funding amount: Up to eight grants of up to CAD 692,000 will be awarded.

• Targeted Sectors/ SDGs: Health, adolescents, SRHR, gender.

• Deadline: August 7, 2025.

• Learn more and apply here.

PKD Foundation Research Grants RFA 2026, PKD Foundation. *New!* *Pre application due soon!*

This funding opportunity supports investigator-led basic, translational, clinical, and epidemiologic research focused on autosomal dominant and autosomal recessive polycystic kidney disease (ADPKD and ARPKD). Areas of interest include molecular pathobiology, predictive and therapeutic strategy development, small pilot clinical studies, secondary data analyses, and studies of care disparities or extra-renal PKD manifestations. The program encourages innovative applications such as machine learning methods, lifestyle interventions, and drug delivery mechanisms. Applicants must hold an MD, PhD (or equivalent) and a faculty-level appointment by the start of funding.

• Geographies: Global (with special consideration for Canada and Australia).

• Who can apply: Researchers with MD, PhD or equivalent and faculty appointment by start of funding.

• Funding amount: Grant of USD $120,000/year for two years ($240,000); optional Young Investigator Award: USD $360,000 over three years.

• Targeted Sectors / SDGs: Health Research; clinical, translational, basic, and epidemiologic PKD research.

• Deadline: Pre‑application August 11, 2025, 5 PM CST; full application: 12 January 2026,  5 PM CST.

• Learn more and apply here.

Proposals that align with PKD Foundation priorities, including ARPKD, pediatric ADPKD, machine learning, lifestyle interventions, extra-renal manifestations, drug delivery mechanisms, and care disparities, and clearly justify clinic fit and budget constraints tend to score highly.

CMIE Development Fund, Canadian Medical Isotope Ecosystem (CMIE). *Closing soon!*

CMIEDF offers financial support to innovators, developers, and academic institutions in Canada, specifically in the field of radiopharmaceutical and medical isotope technologies. This funding is designed to expedite the progress of early-stage programs, thereby creating a continuous pipeline for development and eventual commercialization. For radiopharmaceutical programs, we are seeking programs spanning from the pre-clinical proof of concept phase to early clinical trials and progressing into the pre-commercialization stage.

• Geographies: Canada.

• Who can apply: Innovators, developers, and academic institutions.

• Funding amount: Grants range CAD 200,0000 – 500,000, a total of CA 5M is available. Requires 50% co-financing from non-federal sources.

• Targeted Sectors/ SDGs: Health, research.

• Deadline: August 12, 2025.

• Learn more and apply here.

Reducing Childhood Vulnerability – Health Promotion in Social Initiatives 2025, Novo Nordisk Foundation. *Closing this month!*

The purpose of the call is to 1) give children in vulnerable positions better opportunities for living a healthy life, 2) foster models of cross-sectoral interventions that consider both social and health aspects, 3) gain knowledge about methods on how to best support children in vulnerable positions in living a healthy life, and 4) build capacity and mature organizations working with inequity in health. Applicants can apply for support to projects with a focus on improving the health of children in vulnerable positions by integrating health promoting efforts into social initiatives. Health can include both physical and mental health and/or the link between them. Projects can focus on developing, testing, implementing and/or evaluating initiatives and innovative approaches aimed at promoting health among children in vulnerable positions. The target group is 0-10- year-old children in vulnerable positions, who can also be targeted through interventions focused on the family arena or professionals surrounding them.

• Geographies: Denmark, Greenland and the Faroe Islands.

• Who can apply: Main applicant must be a manager or project manager employed at a non-profit organization or a public institution in Denmark, Greenland, or the Faroe Islands.

• Funding amount: Grants between DKK 1M – 4M for projects lasting between 1 to 5 years.

• Targeted Sectors/ SDGs: Health, mental health, vulnerable children.

• Deadline: August 14, 2025.

• Learn more and apply here.

Lightweight Backpacks Program for Mental Health and Well-being for Teenagers, UNICEF. *New!* *Closing this month!*

UNICEF is seeking a technical partner to co-develop and pilot a multi-pronged adolescent mental health initiative in North Lima, Peru. The program involves validating diagnostic tools, designing training for health and education professionals, developing digital communications, and launching a chatbot for adolescents via WhatsApp. Implemented with the Ministry of Health, the project emphasizes rights-based, gender-sensitive, and inclusive approaches across all components.

• Geographies: Peru (North Lima).

• Who can apply: Technical partners with experience in adolescent health, education, and digital tool development; UN system experience and local presence preferred.

• Funding amount: USD $350,000.

• Targeted Sectors / SDGs: Health, Education, Mental Health / SDG 3, SDG 4, SDG 5.

• Deadline: August 15, 2025.

• Learn more and apply here. Search for Peru in the dropdown menu.

This is a highly localized, co-implementation opportunity requiring in-country presence and strong alignment with public systems.

COVID‑19 Disease Burden on High‑Risk Populations, Pfizer. *New!* *Closing this month!*

Pfizer is funding educational initiatives that target healthcare professionals managing COVID‑19 in adults with high-risk conditions—such as those with immuno-compromise, chronic disease, or post‑COVID sequelae (including long COVID). The aim is to enhance risk recognition, therapeutic decision-making, and patient outcomes through multi-country, multilingual healthcare professional education programs.

• Geographies: Global (excluding the U.S.), with priority in Europe and Asia-Pacific.

• Who can apply: Accredited medical institutions, professional associations, healthcare training providers, and medical schools. Programs must demonstrate reach across countries and languages.

• Funding amount: Up to USD 175,000 per project; total program budget USD 400,000.

• Targeted Sectors / SDGs: Health, vaccine implementation, clinical education (SDG 3).

• Deadline: August 21, 2025 (23:59 Eastern Time).

• Learn more and apply here.

This grant is strictly for educational outreach- not clinical research. Proposals should emphasize scalable training tools for high-risk adult care, ideally delivered in multiple regions and languages.

Sree Ramakrishna Paramahamsa Research Grant – Translational Biomedical Science, Sree Padmavathi Venkateswara Foundation. *New!* *Closing this month!*

This opportunity offers a three‑year translational grant for Indian researchers holding an MD, MS, or PhD (or equivalent), aged below 50 (with age relaxation for women), working at non‑profit institutions in India. The award supports “bench‑to‑bedside” projects that deliver deployable, cost‑effective interventions addressing focused disease-related challenges. Proposals must demonstrate ambitious research with tangible clinical impact by the end of year three and may include international collaborators, provided the lead institution is India‑based.

• Geographies: India.

• Who can apply: Indian non‑profit institutions; PI must hold MD/PhD/MS; lead PI under 50 (5‑year relaxation for women); salary and space must be institutionally secured.

• Funding amount: Grants of up to ₹3 crores over three years (approx. USD $450,000).

• Targeted Sectors / SDGs: Translational Biomedical Research; SDG 3.

• Deadline: August 21, 2025 (preliminary submission).

• Learn more and apply here.

Strong applications clearly map the pathway from a disease‑related research question to an accessible, clinically deployable solution, highlighting translational novelty, feasibility, measurable impact, and justified institutional support.

Regional Entity Proposals, The Pandemic Fund. *Closing this month!*

Now accepting proposals that prioritize high-impact investments across the human, animal, and environment/ecosystem spectrum in the following three programmatic priorities: 1) early-warning and disease- surveillance systems, 2) laboratory systems, and 3) strengthening human resources/public health and community workforce capacity to help countries prevent, prepare for, and respond to health emergencies. Regional Entity Proposals should target public health priorities and challenges affecting a geographic region or sub-region, with emphasis on harmonizing and coordinating approaches across countries. Proposals submitted to the Pandemic Fund must cover one or more of these three programmatic priorities. Regional Entity applicants should ensure that their selected programmatic priority(-ies) strengthen one or both of the two cross-cutting enablers, National Public Health Institutes (NPHIs) (or relevant public institutions) and regional/global networks, organizations, or hubs aimed at bolstering the institutional foundations that support information sharing, coordination across public health and One Health systems, and rapid action

• Geographies: Global.

• Who can apply: Each proposal must include an eligible regional entity as well as an approved implementing agency. Regional Entity(ies) are regional or sub-regional entities, bodies, or platforms that include specialized technical institutions, agencies, multi-country networks, organizations, or hubs established by the governments.

• Funding amount: Proposals from an Established Regional Entity may request up to US $40M, while proposals from a Newly Established Regional Entity may request up to US $15M.

• Targeted Sectors/ SDGs: Health, pandemics, systems strengthening.

• Deadline: August 22, 2025.

• Learn more and apply here.

Supporting Change - Carers, The National Lottery Community Fund. *Closing this month!*

This funding is for projects that will reduce health inequalities for unpaid carers, through systems change- making meaningful and lasting changes to the way things work. So unpaid carers wellbeing is better and they can stay healthy in their caring role. They will not fund the delivery of an existing service. For example, to expand a service into new areas or reduce waiting lists. By unpaid carers they mean adults or children who look after a relative, friend or neighbor. They might look after someone due to a disability, illness, mental health condition, addiction or old age. They are particularly interested in parents that care for a child with additional support needs or disabilities, older people that care for their partner, people that care for someone with an addiction, young carers, LGBTQ+ carers, and ethnically minoritized carers. Proposals must reduce health inequalities that unpaid carers experience by: making long-term changes to the systems that affect unpaid carers’ health, involving people with experience of care in influencing these changes, working and partnering with additional organizations, and using learning and evidence to inform projects,

• Geographies: Scotland.

• Who can apply: Voluntary organizations, community organizations, public sector organizations or partnerships.

• Funding amount: Grants range GBP £500,000 - £2 million for 5 to 10 years. There is also funding available for concept development (up to GBP £50,000).

• Targeted Sectors/ SDGs: Health, care, wellbeing.

• Deadline: August 28, 2025.

• Learn more and apply here.

2025 Device Innovation Challenge, Sanofi. *Idea submission forms open now for teams that registered by July31!* *Closing this month!*

Inviting innovation ideas to address the challenge: How might we envision bold, new possibilities for large-volume drug delivery devices that are digitally enabled and connected, user centric, and respond to the evolving needs of patients? They are looking for innovations that challenge the status quo and reimagine what's possible in the far future—technically, experientially, and systemically.

• Geographies: Global.

• Who can apply: Innovative university students and recent university graduates from 2023 onwards.

• Funding amount: Prizes range USD $50,000 - $1M for the five finalists, with additional potential investments. Important note: Sanofi will retain full Intellectual Property (IP) ownership of the Top 5 Finalist ideas.

• Targeted Sectors/ SDGs: Health, innovation, research.

• Deadline: Idea submission forms open August 1 -31, 2025. Teams must register by July 31, 2025.

• Learn more and apply here.

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 36 open opportunities- 13 new opportunities added!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 4 rolling opportunities!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 3 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 35 open opportunities- 8 new opportunities added!

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 4 rolling opportunities- 2 new opportunities added!

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 3 long term opportunities!

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date.

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible).

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows.

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

Emerging Leader Award, The Mark Foundation. *New!* *Closing soon!*

The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.

• Geographies: US and Canada.

• Who can apply: MD, PhD, or equivalent is required, applicants must be three to eight years from the start of an independent faculty appointment and must be employed by a U.S. or Canadian non-profit academic institution.

• Funding amount: Grant of USD $250,000 per year for three years, totaling $750,000.

• Targeted Sectors/ SDGs: Health, cancer research.

• Deadline: May 5, 2025 (LOI).

• Learn more and apply here.

Improving Climate and Health Policy-making through Applied Systems Thinking, The Alliance for Health Policy and Systems Research. *Closing soon!*

The Alliance for Health Policy and Systems Research is inviting proposals with the objective to apply participatory systems thinking methods to improve national climate and health policy processes. This call seeks to support a total of two research teams across selected countries to apply underused systems thinking methods to enhance national planning and decision-making in climate and health policy processes. Proposals should include applying systems mapping and analysis, conducting structured participatory workshops, engaging in Alliance learning activities, demonstrate pathways toward policy impact.

• Geographies: Islamic Republic of Iran, Mozambique, Nepal and Uganda.

• Who can apply: The Principal Investigator must be a researcher or policy maker based at a university, government agency or registered nongovernmental organization (NGO) working on health policy or climate policy research.

• Funding amount: Grant of up to USD $80,000 each to two research teams.

• Targeted Sectors/ SDGs: Health, systems change, policy, research.

• Deadline: May 5, 2025.

• Learn more and apply here.

The Lighthouse Fund, AVPN. *Closing soon!*

The fund seeks to support organizations developing innovative solutions to address climate and health challenges in Asia. Specifically, they encourage organizations that work in the following impact areas within the climate x health nexus to apply: surveillance and management of climate-sensitive infectious diseases (CSID), and solutions to reduce heat stress and innovations in stable products.

• Geographies: Asia.

• Who can apply: Local and International Non-profit organizations and social enterprises, this includes: charitable nonprofits, public interest organizations, social enterprises, civic institutions, municipalities, labor unions, professional bodies, and associations working on innovative solutions at the intersection of climate and health in Asia.

• Funding amount: US $50,000 - US $200,000.

• Targeted Sectors/ SDGs: Health, public health, climate.

• Deadline: May 9, 2025.

• Learn more and apply here.

The General Grant Program, Coverys Community Healthcare Foundation. *Closing soon!*

CCHF is seeking grant requests from organizations pursuing projects that advance one or more of the following: 1. Programs and initiatives to improve patient care and patient safety; 2. Programs and initiatives that promote healthy lifestyles; and 3. Support of Individuals and organizations who provide health care services. The Foundation has a strong preference to fund innovative projects that support healthcare in the communities served by Coverys policyholders. This preference extends to projects that show evidence of meeting or delivering one or more of the following: a new health need, an improvement in the quality of health care, and/or reduced health costs with better patient outcomes, and supporting underserved communities and patient populations through programs that focus on diversity, equity, and inclusion (DEI).

• Geographies: USA.

• Who can apply: For-profit and non-profit.

• Funding amount: Grant size undisclosed. Total funding around $3 million a year.

• Targeted Sectors/ SDGs: Health, research.

• Deadline: May 14, 2025.

• Learn more and apply here.

RADIAN 2.0, Elton John AIDS Foundation. *Extended deadline!* *Closing soon!*

The RADIAN Initiative seeks to meaningfully address new HIV infections and deaths from AIDS-related illnesses in Eastern Europe and Central Asia (EECA). RADIAN focuses on action, investment, and resources to improve the quality of life, prevention, and care for people at risk of or living with HIV in the region. The Foundation is inviting Concept Notes for ambitious but realistic, sustainable, evidence-informed solutions responding to the overall Goal of the Equity Challenge Fund, Strategic Objective 2 and at least one other Strategic Objective of the RADIAN 2.0 program: Deliver high-quality community-based services to address the unmet HIV-related needs of neglected KPs and PLHIV; Address structural drivers of the HIV epidemic to improve the quality of life of KPs and PLHIV and ultimately improve HIV-related health outcomes; Strengthen health systems to sustainably improve care for KPs and PLHIV; Strengthen community systems to deliver community-led care effectively and increase access to sustainable funding.

• Geographies: Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Romania, Russian Federation, Serbia, Slovenia, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan.

• Who can apply: They encourage Concept Notes and Applications from non-profit, academic and research organizations. They will consider Concept Notes and Applications from commercial entities if their participation is justified and there is no profit included into the project budget. Ineligible entities include individuals and government entities. Government entities may be consortium members.

• Funding amount: Grants range $350,000 - $500,000

• Targeted Sectors/ SDGs: Global health, HIV/AIDS.

• Deadline: May 19, 2025.

• Learn more and apply here.

Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies, Breakthrough T1D. *New!* *Closing this month!*

The goal of this funding opportunity is to improve the efficiency of scaling protocols for manufactured islet cell therapies for type 1 diabetes (T1D) via development of supportive technologies tackling one or more of the barriers associated with implementation and expansion of next-generation beta cell replacement therapies. Breakthrough T1D is soliciting Letters of Intent (LOI) from investigators in academic and industry settings aiming to develop supportive technologies tackling one or more of the barriers associated with adoption of next-generation beta cell replacement therapies and enable the scaling of islet cell therapies for expanded patient populations. Prioritization will be given to projects developing good manufacturing practice (GMP) compatible technologies with a clear plan toward implementation in current workflows. Examples of topics pertinent to this call include but are not limited to: Validation of novel differentiation processes resulting in shorter timelines to insulin producing cells, Development of innovative culture systems for scalable production capacity of pluripotent cell differentiation (e.g., automation), Cell culture processes and technologies that reduce the cost of goods for generating insulin-producing cells, Demonstration of cryoprotective storage solutions for manufactured islets that preserve cell viability and glucose responsive insulin secretion, Identification and validation of critical quality attributes at early stages of differentiation that can predict a successful manufactured run or the applicability of a given protocol to a new cell source.

• Geographies: Global.

• Who can apply: Applications may be submitted by domestic and foreign non-profit organization, public and private, such as universities, colleges, hospitals and laboratories, units of state and local governments and eligible agencies of the federal government, for-profit entities, or industry collaborations with academia. Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent and have a faculty position or equivalent at a college, university, medical school, or other research facility.

• Funding amount: Grant of up to USD $600,000 for two years.

• Targeted Sectors/ SDGs: Health, research.

• Deadline: May 28, 2025 (for LOI).

• Learn more and apply here.

Cervical Cancer Grants Program, TogetHER for Health. *New!* *Closing this month!*

TogetHER’s Cervical Cancer Grants Program provides highly targeted grants for organizations working to address demand and supply constraints related to vaccination, screening, and preventive treatment for HPV and cervical cancer. Interventions supported by this program should be catalytic, improving the lives of program beneficiaries and triggering health system-wide improvements (e.g., policy change, regulatory approval, development of effective tools and strategies) to support cervical cancer elimination efforts. For the 2025-2026 cycle, the Cervical Cancer Grants Program will offer grants to improve both demand and supply of cervical cancer prevention services. Applicants will be required to submit their applications to either of the two tracks: Track 1 aims to improve demand-side interventions to increase uptake of all cervical cancer prevention services. Track 2 aims to support supply-side interventions to accelerate adoption of improved technologies in cervical cancer prevention.

• Geographies: LMIC’s.

• Who can apply: Non-profits.

• Funding amount: Grant of up to USD $30,000 for each track.

• Targeted Sectors/ SDGs: Health, gender, women’s health, HPV.

• Deadline: May 30, 2025.

• Learn more and apply here.

3^rd Call for Proposals (3rd CfP), The Pandemic Fund.

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date.

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible).

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows.

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

2025 Global Health Challenge, MIT SOLVE. *Closing soon!*

MIT Solve seeks exceptional solutions that leverage technology to increase access to good health and healthcare with a particular interest for 2025 in solutions that; 1. Ensure health-related data is collected ethically and effectively and that AI and other insights are accurate, targeted, and actionable in the real world, 2. Increase capacity and resilience of health systems, including workforce, supply chains, and other infrastructure, 3. Increase access to and quality of health services for all communities. Each Solver team receives $10,000 in unrestricted funding from Solve, an additional grant from Johnson & Johnson Foundation, and access to additional financing in the form of grants and investments, this includes access to a pool of +$1.5M in prize funding at selection and additional funding opportunities throughout the program and after.

• Geographies: Global.

• Who can apply: Applicants welcome from all organizations from any stages (concept, prototype, pilot, growth and scale).

• Funding amount: $10,000 - $150,000.

• Targeted Sectors/ SDGs: Health, AI, innovation.

• Deadline: April 17, 2025.

• Learn more and apply here.

The Trinity Challenge: Community Access to Effective Antibiotics, MIT SOLVE. *Closing this month!*

Seeking innovative, low-cost data and technology solutions in LMICs to improve antibiotic stock control and reduce the sale and use of substandard and falsified oral antibiotics. The use and/or generation of community-level data should be integral to solutions. Solutions may relate to human and/or animal health and can respond to either issue of stock control or substandard and falsified oral antibiotics, or both. Solutions might respond to this Challenge by, for example leveraging citizen-related data, applying technology to improve the tracking of antibiotics along the journey from manufacture to patient, tracking community demand, and reporting on shortages and/or predicting stockout, innovation in data capture and/or data analysis relating to stock control or substandard and falsified antibiotics, developing (or updating) more accurate estimates of the prevalence of substandard and falsified antibiotics in a specific community or in a specific part of the supply chain, developing new or improved ways to authenticate antibiotics at the point of sale, developing technology to monitor the effect of climate factors on antibiotic quality, or applying existing technology from other sectors to this issue.

• Geographies: Interventions must be in LMICs. Applicants from all over the world are encouraged to apply. This Challenge particularly encourages solutions from teams based in low- and middle-income countries (LMICs) and multi-disciplinary teams.

• Who can apply: A wide range of applicants, solutions proposed must be at least proof of concept phase.

• Funding amount: A prize fund of up to £1,000,000 will be awarded, with an aim to award a grand prize of £500,000 in each category of the Challenge (Stock Control and Substandard and Falsified Antibiotics).

• Targeted Sectors/ SDGs: Health, antibiotic resistance.

• Deadline: April 24, 2025.

• Learn more and apply here.

CapitaLand Community Resilience Initiative, AVPN. *New!*

The CapitaLand Community Resilience Initiative is a SGD 3 million initiative, supported by AVPN, dedicated to strengthening community resilience across Asia. Focusing on education, health, and well-being, the initiative is designed to support vulnerable groups, especially children and youth in the priority countries. By focusing on children and youth, the CapitaLand Community Resilience Initiative aims to equip this group with the skills, knowledge and support systems needed to thrive in the face of adversity, driving economic growth and strengthening their resilience to ensure a stronger, more adaptive and equitable future. The Initiative is committed to supporting solutions that build social capital and resilience in local communities and encourage eligible non-profits that work in the following impact areas focusing on children and youth (up to the age of 21 years) to apply: education, skills development, physical health, mental health and well-being support.

• Geographies: China, India, Singapore and Vietnam.

• Who can apply: Non-profits operating in at least one of the priority countries.

• Funding amount: A total of S$3 million SGD in grants will be disbursed to awardee organizations by the end of 2025.

• Targeted Sectors/ SDGs: Physical health, mental health and well-being support

• Deadline: April 25, 2025.

• Learn more and apply here.

Call for Innovative WASH Solutions, UNICEF Sustainable WASH Innovation Hub. *New!* *Closing this month!*

Is looking for proven innovative WASH solutions with potential for accelerated scale.

This Call for Applications is intended for solutions that address systemic problems for WASH. They are seeking a diverse range of innovative solutions, including but not limited to programmatic models, private sector approaches, public sector strategies, and other relevant models.

The WASH Innovation Hub is seeking proven solutions addressing one or both of the following innovation challenges: 1: Strengthening supportive environments for WASH SMEs, 2. Enhancing climate-sensitive data and integration into WASH programming.

• Geographies: UNICEF program countries.

• Who can apply: Any for profit or non-profit that is a legally registered entity such as a university spin-off, NGO, UN organization or Government agency.

• Funding amount: Grant of up to USD $150,000 USD in flexible funds to support evidence generation, feasibility studies, and market understanding and assessments.

• Targeted Sectors/ SDGs: WASH, health, water.

• Deadline: April 30, 2025.

• Learn more and apply here.

Climate Impacts Awards: Unlocking Urgent Climate Action by Making the Health Effects of Climate Change Visible, Wellcome. *Closing this month!*

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date.

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible).

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows.

This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities.

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates / free membership for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.

Open Calls:

VOA Futures Fund Community Health Incubator 2025, Volunteers of America and Humana Foundation. *Closing soon!*

Read more

The grants are organized into three categories:

1. Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date.

2. Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible).

3. Long term planning: Grants that have closed their current rounds, but are expected to open new windows.

Subscribe to the newsletter to stay up to date on the latest funding opportunities in Global Health.

Subscribe now

Open Calls:

Data for Health (D4H) Initiative - Global Grants Program (GGP), Bloomberg Philanthropies Data for Health Initiative. *New!*

Has launched a new round of funding for projects in the area of Civil Registration and Vital Statistics (CRVS) and Data Use. This funding call includes an optional focus on Digital Strategies for CRVS Systems Strengthening and Data Use. Digital strategies are poised to bridge gaps in global health equity and they welcome applications that also choose to focus on this theme within CRVS and Data Use, including but not limited to the following examples: Digitalizing CRVS systems for improved birth and death registration processes, Establishing interoperability between CRVS systems, health, and/or access to public and private services such as ID, Well-designed dashboards, Data portals, Interactive reports. Projects should be aligned to the objectives of the D4H Initiative: strengthening civil registration and vital statistics systems, using public health data for policy development and program planning, and cancer registration.

• Geographies: Low-and middle-income countries that have not received funding from the D4H Initiative.

• Who can apply: Ministries of health, statistical agencies, and other relevant agencies at the national, subnational, or municipal levels.

• Funding amount: Grant up to USD $100,000 (for 15 months), shorter-term grants with lower award amounts are also encouraged.

• Targeted Sectors/ SDGs: Health.

• Deadline: February 17, 2025.

• Learn more and apply here.

Mobile Health: Technology and Outcomes in Low and Middle Income Countries, The National Institutes of Health. *May be significantly affected by US policy changes*

Accepting submissions for exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, and/or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs. This opportunity provides support for up to two years for technology development and feasibility studies, followed by a possible transition to expanded research support for validation, larger-scale feasibility, and effectiveness studies.

• Geographies: Low- and middle-income countries (LMICs).

• Who can apply: Global non-profits and for-profits organizations. US applicants are required to involve LMIC researchers as key personnel

• Funding Amount: Grant of up to USD $125,000.

• Targeted Sectors/ SDGs: Health, mHealth solutions, innovation.

• DEADLINE: Letter of Intent (LOI) February 21, 2025, full application March 21, 2025.

• Learn more and apply here.

Connected Healthy Lives: 2025 Grant Cycle, Humana Foundation. *New!*

The Humana Foundation partners with local communities and community organizations to create a network of support for people confronting life’s challenges, regardless of their age, race, ethnicity, or gender identity. They support programs and services committed to suicide prevention, substance abuse treatment, foster grandparent programs, as well as programs to advance nutritional literacy and food security.

• Geographies: USA: Louisville, KY, Texas, Florida and Louisiana.

• Who can apply: US nonprofits.

• Funding Amount: There is no maximum or minimum amount allowed, organizations are invited to submit multi-year program and funding requests.

• Targeted Sectors/ SDGs: Health, food security, nutrition, community programming.

• DEADLINE: February 21, 2025.

• Learn more and apply here.

  ---

VOA Futures Fund Community Health Incubator 2025, Volunteers of America and Humana Foundation. *New!*

Incubator with a mission to accelerate social enterprises that improve quality, equity, and access to care for Medicaid and at-risk populations. The incubator supports early-stage entrepreneurship that develops innovative products and services for equitable community health outcomes. Focus issue areas include solutions supporting seniors, veterans, youth, unhoused, and/or working in mental and behavioral health.

• Geographies: USA. Strong preference is given to businesses able to agilely partner with VOA Affiliates in California, Florida, Kentucky, Louisiana, or Texas.

• Who can apply: Both for profit and nonprofit enterprises.

• Funding Amount: Founders receive a $15,000 non-dilutive capacity grant, additional $10,000 may be accessed for implementation pilots with VOA Affiliates. Graduates are eligible for follow-on investments of up to $200,000.

• Targeted Sectors/ SDGs: Health, mental health.

• DEADLINE: March 3, 2025.

• Learn more and apply here.

Pioneer Innovator Grant-Health, Novo Nordisk Foundation. *New!*

Seek to accelerate the commercialization of research findings and the development of novel technologies within health. The Pioneer Innovator Grant Health seeks to support innovative research within med-tech, industrial biotech, pharma as well as quantum technologies. Pioneer Innovator Grants seek to support novel academic science-based discoveries with commercial potential. The grant aims to stimulate the evaluation of ideas and to support experiments and activities leading to proof-of-concept or beyond.

• Geographies: Global.

• Who can apply: Lead applicant must be from a non-profit research institution in Denmark, Finland, Iceland, Norway, or Sweden. Co-applicants may come from the same hosting institution as the main applicant or from a different university, hospitals, or research institutions locally and abroad.

• Funding Amount: Grant of DKK 1.1 million per project.

• Targeted Sectors/ SDGs: Health, innovation.

• DEADLINE: March 13, 2025.

• Learn more and apply here.

The Distinguished Innovator Grant-Health, Novo Nordisk Foundation. *New!*

The purpose of the grant is to accelerate commercialization of research findings and development of novel technologies within health. The Distinguished Innovator Grant-Health seeks to support innovative research within med-tech, industrial biotech, pharma as well as quantum technologies. Furthermore, the intend is to stimulate the evaluation of ideas that for example could lead to the development of new medical treatment, disease prevention, diagnostic methods as well as new health technologies, devices and technological platforms. Particular focus will be placed on projects covering cardiometabolic diseases as well as infectious diseases and preventive solutions hereto. All applications must have a clear outlook to scaling potentials and later commercialization possibilities.

• Geographies: Global.

• Who can apply: Lead applicant must be from a non-profit research institution in Denmark, Finland, Iceland, Norway, or Sweden. Co-applicants may come from the same hosting institution as the main applicant or from a different university, hospitals, or research institutions locally and abroad.

• Funding Amount: Grant of DKK 6.8 million per project.

• Targeted Sectors/ SDGs: Health, innovation.

• DEADLINE: March 13, 2025.

• Learn more and apply here.

Zayed Sustainability Prize- Health, Zayed Sustainability Prize.

Recognizes organizations that have demonstrated innovative, impactful and inspirational sustainability solutions in the areas of health that include, but are not limited to: ensuring access to essential and affordable healthcare, ensuring access to maternal and newborn healthcare, Ending epidemics (AIDS, Malaria, Tuberculosis etc.), Preventing and treating water-borne, communicable and non-communicable diseases, Reducing illness from pollution, hazardous chemicals and contamination. Applicants must also demonstrate a clear vision and long-term plan to further deploy their solution and scale up their impact, as well as inspiring others to follow suit by advancing sustainable and human development.

• Geographies: Global.

• Who can apply: SME’s and non-profits.

• Funding amount: Prize fund of US $1 million.

• Targeted Sectors/ SDGs: Health.

• Deadline: June 23, 2025.

• Learn more and apply here.

Novo Nordisk Prize 2025, Novo Nordisk Foundation. *New!*

The Novo Nordisk Prize recognizes an active scientist who has provided outstanding international contributions to advance medical science for the benefit of people’s lives. The Prize is intended to award and further support biomedical research in Europe.

• Geographies: European based individuals.

• Who can apply: Nominees must have a current position and an active research program at a public, non-profit research institution and/or in a company based in a European country, but can be from any nationality.

• Funding amount: The Prize is of DKK 5 million (appr. EUR 672,000) and consists of a DKK 4,5 million (appr. EUR 605,000) research grant and a personal award of DKK 0,5 million (appr. EUR 67,000).

• Targeted Sectors/ SDGs: Health

• Deadline: August 1, 2025.

• Learn more and apply here.

Rolling Applications:

Global Health & Development Fund, Founders Pledge. *New!*

The Global Health & Development Fund (GHDF) aims to significantly improve the lives of the world's most vulnerable people, support sustainable, systemic change, and eliminate deaths from easily preventable disease. Global health and development fund is especially interested in programs that can, in expectation, save a life for under $4,000, avert a DALY for under $70, or double income for one person at a cost of less than $30. Note that this includes interventions that affect economic growth.

• Geographies: Global.

• Who can apply: Non-profits.

• Funding amount: Typically make small grants of between $50,000 and $300,000 from our various Funds, though in special cases we would consider larger sums. Can recommend much larger one-time grants of up to $5m to large donors.

• Targeted Sectors/ SDGs: Health

• Deadline: Applications accepted on a rolling basis.

• Learn more and apply here.

Long Term Planning:

Discovery Research Grants, Worldwide Cancer Research. *Next round opens Spring 2025*

is seeking to fund novel, exciting and creative ideas that could help prevent, diagnose or treat cancer. Grants to support basic, fundamental or translational research into the prevention, diagnosis or treatment of cancer. They are looking for innovative research that takes intellectual risks, proposals with a creative approach to answering fundamental questions that could change how they think about cancer (that may be looked over by other funders), and support blue-sky thinking in research and want to direct funding towards projects that could transform an area of cancer research or one day have a major impact on the lives of people with cancer.

• Geographies:

• Who can apply:

• Funding amount: Grants typically 200,000- 275,000 GBP for 12-36 months.

• Targeted Sectors/ SDGs: Health.

• Deadline: Next round opens spring 2025.

• Learn more and apply here.

All content is currently open and free as we transition to Substack. Starting mid-February 2025, access to the full list of opportunities on this page will be available to paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Thank you for being part of the Impact Funding community!

Subscribe now

To keep this accessible to everyone who needs it, we’re happy to offer discounted rates for nonprofits and individuals from LMICs (Low- and Middle-Income Countries). Message us below for more information.